Vicilin-like Seed Storage Protein Gene Promoter And Methods Of Using The Same by Perera, Ranjan et al.
(12) United States Patent 
Perera et al. 
(54) VICILIN-LIKE SEED STORAGE PROTEIN 
GENE PROMOTER AND METHODS OF 
USING THE SAME 
(75) Inventors: Ranjan Perera, San Diego, CA (US); 
John Cairney, Decatur; Gerald S. 
Pullman, Alpharetta, both of GA (US) 
(73) Assignee: Institute of Paper Science and 
Technology, Inc., Atlanta, GA (US) 
( *) Notice: Subject to any disclaimer, the term of this 
patent is extended or adjusted under 35 
U.S.C. 154(b) by 0 days. 
(21) Appl. No.: 09/323,195 
(22) Filed: Jun. 1, 1999 
(51) Int. Cl.7 .......................... C12N 5/04; C12N 15/09; 
C12N 15/29; C12N 15/82; AOlH 5/00 
(52) U.S. Cl. ....................... 800/287; 800/278; 800/292; 
800/293; 800/294; 800/295; 435/69.1; 435/468; 
536/23.1; 536/23.6; 536/24.1 
(58) Field of Search ................................. 800/278, 287, 
800/292, 293, 294, 295; 435/69.1, 468; 
536/23.1, 24.1, 23.6 
(56) References Cited 
CA 
CA 
U.S. PATENT DOCUMENTS 
5,470,359 A 
5,484,718 A 
5,498,831 A * 
5,514,584 A 
5,525,716 A 
5,543,576 A 
5,589,614 A 
5,593,963 A 
5,612,472 A 
5,616,474 A 
5,633,439 A 
5,646,333 A 
5,659,026 A 
5,670,349 A 
5,677,151 A 
5,684,239 A 
5,689,053 A 
5,712,112 A 
5,723,764 A 
11/1995 
1/1996 
3/1996 
5/1996 
6/1996 
8/1996 
12/1996 
1/1997 
3/1997 
4/1997 
5/1997 
7/1997 
8/1997 
9/1997 
10/1997 
11/1997 
11/1997 
1/1998 
3/1998 
Huffman ........................ 47/58 
Schofield et al. ........ 435/172.3 
Burgess et al. . . . . . . . . . . . . . 800/205 
Lastick et al. ........... 435/252.3 
Olsen et al. ............... 536/24.1 
van Ooijen et al. ........ 800/250 
Bridges et al. . . . . . . . . . . . . . 800/205 
Van Ooijen et al. .......... 514/12 
Wilson et al. ............. 536/24.1 
Bolotin et al. ............. 435/69.1 
Walter ........................ 800/205 
Dobres et al. .............. 800/205 
Baszczynski et al. ...... 536/24.1 
Cramer et al. ........... 435/172.3 
Wilson et al. ................ 435/72 
Wu et al. . . . . . . . . . . . . . . . . . . . 800/205 
Robert et al. ............... 800/205 
Yu et al. .................... 435/69.1 
Nichols et al. . . . . . . . . . . . . . 800/205 
FOREIGN PATENT DOCUMENTS 
2014264 
2192106 
10/1990 
6/1997 
OIBER PUBLICATIONS 
Kim et al. Plant Molecular Biology, vol. 24, pp. 105-117, 
1997.* 
Ammirato, "The regulation of somatic embryo development 
in plant cell cultures: Suspension culture techniques and 
hormone requirements," Bio/Technology, 1983, 1, 68-74. 
Ausubel et al., Current Protocols in Molecular Biology, 
John Wiley & Sons, New York, 1989, 2.3.1-2.3.3. 
Bapat et al., "Occurrence and frequency of precocious 
germination of somatic embryos is a genotype-dependent 
phenomenon in wheat," Plant Cell Rep., 1988, 7, 538-541. 
I lllll llllllll Ill lllll lllll lllll lllll lllll 111111111111111111111111111111111 
US006462257Bl 
(10) Patent No.: US 6,462,257 Bl 
Oct. 8, 2002 (45) Date of Patent: 
Becwar et al., "Initiation of embryogenic cultures and 
somatic embryo development in loblolly pine (Pinus 
taeda)," Can. J. For. Res., 1990, 20, 810-817. 
Braun et al., "A vicilin-like seed protein of cycads: simi-
larity to sucrose-binding proteins," Plant Mal. Biol., 1996, 
31, 35-44. 
Church et al., "Genomic sequencing," Proc. Natl. Acad. Sci. 
USA, 1984, 81, 1991-1995. 
Crouch, "Non-zygotic embryos of Brassica napus L. con-
tain embryo-specific storage protein," Planta, 1982, 156, 
520-524. 
da Silva et al.," A cotyledon regulatory region is responsible 
for the different spatial expression patterns of Arabidopsis 
2S albumin genes," Plant J., 1994, 5( 4), 493-505. 
de Pater et al., "A 22-bp Fragment of the Pea Lectin 
Promotor Containing Essential TGAC-like Motifs Confers 
Seed-Specific Gene Expression," Plant Cell, 1993, 5, 
877-886. 
Gander et al., "Isolation, characterization and expression of 
a gene coding for a 2S albumin from Bertholletia excelsa 
(Brazil nut)," Plant Mal. Biol., 1991, 16, 437-448. 
Goldberg et al., "Regulation of Gene Expression during 
Plant Embryogenesis," Cell, 1989, 56, 149-160. 
Guerche et al., "Differential Expression of the Arabidopsis 
2S Albumin Genes and the Effect of Increasing Gene Family 
Size," Plant Cell, 1990, 2, 469-478. 
Higgins, "Synthesis and Regulation of Major Proteins in 
Seeds," Ann. Rev. Plant Physiol., 1984, 35, 191-121. 
Kawagoe et al., "Synergism between CACGTG (G-box) 
and CACCTG cis--elements is required for activation of 
bean seed storage protein 3-phaseolin gene," Plant J., 1994, 
5, 885-890. 
Krochko et al., "Contrasting Storage Protein Synthesis and 
Messenger RNA Accumulation during Development of 
Zygotic and Somatic Embryos of Alfalfa (Medicago sativa 
L.)," Plant Physiology, 1992, 99, 46-53. 
Laden et al., "Development regulation of beta--conglycinin 
in soybean axes and cotyledons," Plant Physiol., 1987, 84, 
35-41. 
Lessard et al., "Upstream regulatory sequences from two 
beta-conglycinin gene," Plant Mal. Biol., 1993, 22, 
873-885. 
(List continued on next page.) 
Primary Examiner-Phuong T. Bui 
Assistant Examiner-Medina A Ibrahim 
(74) Attorney, Agent, or Firm-Woodcock Washburn LLP 
(57) ABSTRACT 
The present invention provides novel vicilin-like gene pro-
moters. The promoter of the present invention may be 
operably linked to a desired sequence such as a gene or 
fragment thereof. A promoter-gene construct is also embod-
ied by the present invention. Methods of producing and 
expressing polypeptides in plants are also provided. The 
present invention further provides methods for monitoring 
the embryo development of conifers. 
23 Claims, 11 Drawing Sheets 
US 6,462,257 Bl 
Page 2 
OIBER PUBLICATIONS 
Muntz, "Developmental control of storage protein formation 
and its modilation by some internal and external factors 
during embryogenesis in plant seeds," Biochem., Physiol. 
Pflnazen, 1987, 182, 93-116. 
Newton et al., "Vicilin-like seed storage proteins in the 
gymnosperm interior spruce (Picea glauca/engelmanii)," 
Plant Mal. Biol., 1992, 20, 315-322. 
Pang et al., "Molecular cloning, genomic organization, 
expression and evolution of 12S seed storage protein genes 
of Arabidopsis thaliana," Plant Mal. Biol., 1988, 11, 
805-820. 
Pullman et al., "An Embryo Staging System for Comparison 
of Zygotic and Somatic Embryo Development," TAPPI 
R&D Division Biological Sciences Symposium, Minneapo-
lis, Minnesota, Oct. 3-6, 1994, 31-33. 
Senaratna et al., "Desiccation tolerance of alfalfa (Medicago 
sativa L.) Somatic embryos: Influence of abscisic acid, 
stress pre treatments and drying rates," Plant Sci., 1989, 65, 
253-259. 
Shoemaker et al., "Storage protein accumulation patterns in 
somatic embryos of cotton (Gossypium hirsutum L.)," Plant 
Cell Rep., 1987, 6, 12-15. 
Shotwell et al., "The Biochemistry and Molecular Biology 
of Seed Storage Proteins," in The Biochemistry of Plants: A 
Comprehensive Treatise, Academic Press, San Diego, CA, 
vol. 15, Ch. 7, 1989, 297-345. 
Steward et al., "Growth and development of cultured plant 
cells," Science, 1964, 143, 20-27. 
Thomas, "Gene Expression During Plant Embryogenesis 
and Germination: An Overview," Plant Cell, 1993, 5, 
1401-1410. 
Thomas et al., "Identification of an Enhancer Element for 
the Endosperm-Specific Expression of High Molecular 
Weight Glutenin," Plant Cell, 1990, 2, 1171-1180. 
Wallace et al., "Nucleotide Sequence of a cNDA Clone 
Corresponding to the Maize Globulin-2 Gene," Plant 
Physiol., 1991, 95, 973-975. 
Walling et al., "Transcriptional and post-transcriptional 
regulation of soybean seed protein mRNA levels," Proc. 
Natl. Acad. Sci. USA, 1986, 83, 2123-2127. 
Wenck et al., "High-efficiency Agrobacterium-mediated 
transformation of Norway spruce (Picea abies) and loblolly 
pine (Pinus taeda)," Plant Mal. Biol., 1999, 39(3), 407-416. 
Miki et al., "Procedures for Introducing Foreign DNA into 
Plants," in Methods in Plant Molecular Biology and Bio-
technology, Glick, B.R. et al. (eds.), CRC Press, Inc., 1993. 
Sambrook et al., Molecular Cloning, A Laboratory Manual, 
Cold Spring Harbor Laboratory Press, NY, 1989. 
* cited by examiner 
U.S. Patent Oct. 8, 2002 Sheet 1 of 11 US 6,462,257 Bl 
* 20 * 40 * 60 
ACTATAGGGCACGCGTGGTCGAcGGCCCGGGcTGGTAAA GTGTGTGTTTGCAGGGTGCAGA 
53: ACTATAGGGCACGCGTGGTCGACGGCCCGGGCTGGTAAA-GTGTGTGTTTGCAGGGTGCAGA :61 
54: ACTATAGGGCACGCGTGGTCGACGGCCCGGG-TGGTAAA-GTGTGTGTTTGCAGGGTGCAGA :60 
51: ACTATAGGGCACGCGTGGTCGACGGCCCGGGCTGGTAAAAGTGTGTGTTTGCAGGGTGCAGA :62 
52: ACTATAGGGCACGCGTGGTCGA-GGCCCGGGCTGGTAAAAGTGTGTGTTTGCAGGGTGCAGA :61 
* 80 * 100 * 120 
TAATGGCAGCATGTATGACATTAGACATATGGCATTGGCAAATGCT TCGATTTTGGCACTC 
53: TAATGGCAGCATGTATGACATTAGACATATGGCATTGGCAAATGCTATCGATTTTGGCACTC:123 
54: TAATGGCAGCATGTATGACATTAGACATATGGCATTGGCAAATGCTATCGATTTTGGCACTC:l22 
51: TAATGGCAGCATGTATGACATTAGACATATGGCATTGGCAAATGCTGTCGATTTTGGCACTC:l24 
52: TAATGGCAGCATGTATGACATTAGACATATGGCATTGGCAAATGCTGTCGATTTTGGCACTC:l23 
* 140 * 160 * 180 
ATCACTGTAATTGTTGCAACATGTCAATCGTCtGCAaCATGCCCTGG GATCATAGGTTATG 
53: ATCACTGTAATTGTTGCAACATGTCAATCGTCTGCAGCATGCCCTGGCGATCATAGGTTATG:185 
54: ATCACTGTAATTGTTGCAACATGTCAATCGTCTGCAACATGCCCTGGCGATCATAGGTTATG:184 
51: ATCACTGTAATTGTTGCAACATGTCAATCGTCTGCAACATGCCCTGGTGATCATAGGTTATG:186 
52: ATCACTGTAATTGTTGCAACATGTCAATCGTCCGCAACATGCCCTGGTGATCATAGGTTATG:185 
* 200 * 220 * 240 
CAAGAACTCAGA GtGTTCACCaTTCTTCAATACCAaATGCCTCTTCTGTCTGGTTGCTTCC 
53: CAAGAACTCAGATGTGTTCACCATTCTTCAATACCAAATGCCTCTTCTGTCTGGTTGCTTCC:247 
54: CAAGAACTCAGATGAGTTCACCATTCTTCAATACCAAATGCCTCTTCTGTCTGGTTGCTTCC:246 
51: CAAGAACTCAGACGTGTTCACCATTCTTCAATACCATATGCCTCTTCTGTCTGGTTGCTTCC:248 
52: CAAGAACTCAGACGTGTTCACCGTTCTTCAATACCAAATGCCTCTTCTGTCTGGTTGCTTCC:247 
* 260 * 280 * 300 
ACCACGCGTCCATGCATG CATGATTCTCTTGTATATAAAAGTCCCCCTTGCCCATTCTGT 
53: ACCACGCGTCCATGCATGCACATGATTCTCTTGTATATAAAAGTCCCCCTTGCCCATTCTGT:309 
54: ACCACGCGTCCATGCATGCACATGATTCTCTTGTATATAAAAGTCCCCCTTGCCCATTCTGT:308 
51: ACCACGCGTCCATGCATGTGCATGATTCTCTTGTATATAAAAGTCCCCCTTGCCCATTCTGT:310 
52: ACCACGCGTCCATGCATGTGCATGATTCTCTTGTATATAAAAGTCCCCCTTGCCCATTCTGT:309 
320 * 340 
CTAGTACC GACTTCACCAAAGCACCATCATG 
53: CTAGTACC-GACTTCACCAAAGCACCATCATG :340 
54: CTAGTACCAGACTTCACCAAAGCACCATCATG :340 
51: CTAGTACCGGACTTCACCAAAGCACCATCATG :342 
52: CTAGTACCGGACTTCACCAAAGCACCATCATG :341 
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AAAGCACCATCATGGCTTTTGTTTCTTTACTTACCATTCTTCAAGCAATCTCCTCCTGCTCCGTT 
GCTCTCACTGAGCCACTAGCCACTGTGGCCAATCAAGGAGTTTTTCCTGAAGATCATGGGCGA 
GGGCACCAGAGACGAGAAGAAGAACGAGAGGAGAATCCGTACGTATTCCACAGTGACAGAT 
TCAGGATGAGAGCGTCATCTGACGCTGGTGAAATCAGAGCTCTCCCCAACTTTGGTGAGGCCT 
CTGAACTTCTTGAAGGGATTAGTAAATACAGAGTTACCTGCATTGAAATGAGACCCAACACGG 
TCATGCTCCCTCACTATCTTGACGCGACATGGATTrrATATGTTACTGGAGGAAGAGGTTACAT 
AGCTTACGTGCACCAGAATGAACTGGTGAAAAGAAAGTTGGAGGAAGGAGATGTATTTGGTG 
TTCCAAGTGGTCATACATTTTATCTCGTTAACAACGATGACCACAACAGCCTTCGCATTACCA 
GTCTCCTGCGTACAGTGTCTACGATGCGAGGAGAATATGAGCCCTACTACGTTGCTGGAGGTC 
GGAATCCTGAGACTGTTTACTCTGCCTTTAGCGATGATGTTCTCGAAGCTGCATTCAATACGA 
ACGTTATAGAAGCTAGAACACATTTTCCGGTGCACATAGAACGGGAGTCATATTCCATGGCAA 
ATGAAGAACAGATTAGAGAAATGTTGAGGAAACGGGGATTTTCAGCAGAATCCATGTCTGCA 
TCTGAGCACCCAAAGCCTTTTAACCTTCGGAACCAGAAGCCAGATTTCGAGAACGACAATGGC 
AGGTrrACTAGAGCTGGTCCCAATGAAAATCCTCTTCTTGACGCGGTCGATGTTACTGCTGGG 
TTTGGCGTTTTGAATCCTGGAACCATGACAGCCCCATCTCACAACACGAAAGCAACCTCAATC 
GCCATTGTCACACAGGGGGAGGGAAGGATTGAGATGGCGTGCCCGCACCTTGGTCAACATGG 
CTGGTCTAGTCGGCGCGAGAAAGGCGATCAGGAAATTAATTACCAGAGGGTACGGGCAAGGC 
TGAGAACCGGCACCGTTTACGTTGTTCCTGCAGGTCATCCAATCACCGAGATAGCTTGCACAG 
AGGGCCACCTTGAAATCTTGTGGTTTGATATTAATACGAGCGGCAACGAGAGACAATTCCTGG 
CAGGAAAGTACAATGTGCTTCAAACGCTGGAGAAGGAGGTCAGGCAGATATCCTTCAACATA 
CCACGTGGGGAAGAGCTGGATGAAGTTTTACGGCGGCAAAAGGATCAAGTCATCCTCAGAGG 
GCCCCAAATGCAAAGGCGAGACGAGCCAAGGAGCTCTTCTTAGATCCATGCCATCATCGCAG 
CTCGCATCATGGACGACAAGACTAGAGTTTCTCCACGTTCACTCTTTAGTATCTACTTAAGAAT 
AAGTTATGCATATATGAAGCCCAAAAAATGTGTTCGAAGATGAGCTCCTTTTATCTTAATGAA 
TGTATATATGAGTTTCAACAAACCTATCGTTGGGCTCTTCTCTTGCTACTTCAATGACATGGAA 
TGCTGATCTT 
!F/!j. J 
STIMAFVSLLTILQAISSCSVALTEPLATVANQGVFPEDHGRGHQRREEEREENPYVFHS 
DRFRMRASSDAGEIRALPNFGEASELLEGISKYRVTCIEMRPNTVMLPHYLDATWILYVT 
GGRGYIAYVHQNELVKRKLEEGDVFGVPSGHTFYLVNNDDHNSLRITSLLRTVSTMRGEY 
EPYYVAGGRNPETVYSAFSDDVLEAAFNTNVIEARTHFPVHIERESYSMANEEQIREMLR 
KRGFSAESMSASEHPKPFNLRNQKPDFENDNGRFTRAGPNENPLLDAVDVTAGFGVLNPG 
TMTAPSHNTKATSIAIVTQGEGRIEMACPHLGQHGWSSRREKGDQEINYQRVRARLRTGT 
VYVVPAGHPITEIACTEGHLEILWFDINTSGNERQFLAGKYNVLQTLEKEVRQISFNIPR 
GEELDEVLRRQKDQVILRGPQMQRRDEPRSSS*IHAIIAARIMDDKTRVSPRSLFSIYLR 
ISYAYMKPKKCVRR*APFILMNVYMSFNKPIVGLFSCYFNDMEC*S 
• indicates potential stop signal 
* 20 * 40 * 60 * 80 
STIMAFASLLIILLAISSCSAALTEPLA3TANPEVFPEDHGRGHGRREEEREENPYVFHSDRFRMRASSDAGEIRALPNFG 
L. Pine : STIMAFVSLLTILQAISSCSVALTEPLATVANQGVFPEDHGRGHQRREEEREENPYVFHSDRFRMRASSDAGEIRALPNFG : 81 
P. Glauca : ---MALASLLIILLAISSSSAALTEPLASTANPEVFPEYLGRGRGRREEEREENPYVFHSDSFRTRASSEAGEIRALPNFG : 78 
* 100 * 120 * 140 * 160 
EASELLEGIRK5RVTCIEM4PNTVMLPHY6DATWILYVTGGRGYIAYVHQNELVKRKLEEGDVFGVPSGHTFYLVNNDDHN 
L. Pine : EASELLEGISKYRVTCIEMRPNTVMLPHYLDATWILYVTGGRGYIAYVHQNELVKRKLEEGDVFGVPSGHTFYLVNNDDHN : 162 
P. Glauca : EVSE1LEGIRKFRVTCIEMKPNTVM1PHYIDATWI1YVTRGRGYIAYVHQNELVKRK1EEGDVFGVPSGHTFY1VNNDDHN : 159 
* 180 * 200 * 220 * 240 
31RIASL6RPVST6RGEY2P5YVAGGRNP2TVYSAFSDDV1EAAFNTNVI2AERHFGGHIEGESIIHANEEQIREM6RKRG 
1. Pine : S1RITS1LRTVSTMRGEYEPYYVAGGRNPETVYSAFSDDV1EAAFNTNVIEARTHFPVHIERESYSMANEEQIREMLRKRG : 243 
P. Glauca : T1RIAS1VRPVSTVRGEYQPFYVAGGRNPQTVYSAFSDDV1EAAFNTNVQQ1ERIFGGHKSG-VIIHANEEQIREMMRKRG : 239 
* 260 * 280 * 300 * 320 
FSAESMSAPEHPKPFN1RNQKPDFENDNGRFTIAGPKENPF1DA6DV3AGFAD1NPG3MTAPSHN3KATSIAIVTNGEGRI 
1. Pine : FSAESMSASEHPKPFNLRNQKPDFENDNGRFTRAGPNENP1LDAVDVTAGFGVLNPGTMTAPSHNTKATSIAIVTQGEGRI : 324 
P. Glauca : FSAGSMSAPEHPKPFN1RNQKPDFENENGRFTIAGPKNYPFLDA1DVSVG1AD1NPGSMTAPSLNSKSTSIGIVTNGEGRI : 320 
* 340 * 360 * 380 * 400 
EMACPH1GQHGWSSPRE4GDQDINYQRVRA41RTG3VY6VPAGHPITEIACTEGH12ILWFD6NTRGNERKFLAGKNNVLN 
1. Pine : EMACPH1GQHGWSSRREKGDQEINYQRVRAR1RTGTVYVVPAGHPITEIACTEGH1EILWFDINTSGNERQF1AGKYNV1Q : 405 
P. Glauca : EMACPHLGQHGWSSPRERGDQDITYQRVWAK1RTGSVYIVPAGHPITEIASTNSRLQILWFD1NTRGNERQFLAGKNNVLN : 401 
* 420 * 440 * 
T1E4E6RQ6SFN6PRGEE6DEV1QAQKDQVI1RGPQMQRRDEARSS 
L. Pine : TLEKEVRQISFNIPRGEELDEV1RRQKDQVILRGPQMQRRDEPRSS : 451 
P. Glauca : T1EREIRQLSFNVPRGEEIEEVLQAQKDQVI1RGPQRRSRDEARSS : 447 
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20 * 40 * 60 * 80 * 100 * 120 
AAGCA CATCATGGCTTT G T~CTTTACTTA CATTCTTC GCAATCTCCTCCT CTC G TGC CTCACTGAGCCACTAGCCA GGCCAATC AG AGTTTTTCCTGA.A ATC GG CGAGG 
L.Pine : AAAGCACCATCATGGCTTTTGTTTCTTTACTTACCATTCTTCAAGCAATCTCCTCCTGCTCCGTTGCTCTCACTGAGCCACTAGCCACTGTGGCCAATCAf.GGAGTTTTTCCTGAAGATCATGGGCGAGG 
P .G ~au ca : CAAGCATCATC.~ TGGCTTTAGCTTCTTTACTTATCATTCTTCTTGCAA TCTCCTCCTCCTCGGC TGCCCTCACTGAGCCACTAGCCAGCACGGCCAA TCCAGAAGTT TTTCCTGAA TATCTCGGCCGAGG 
140 * 160 * 180 * 200 ' 220 * 240 t 260 
C GAGACGAGAAGAAGA CGAGAGGAGAATCC TA GTATTCCACAGTGACAG TTC GGA AGAGC TCATCTGA GCTGGTG.~TCAGAGCTCT CC AACTTTGG GAGG CTCTGAACTT 
L.Pine : GCACCAGAGACGAGAAGAAGAACGAGAGGAGAATCCGTACGTATTCCACAGTGACAGATTCAGGATGAGAGCGTCATCTGACGCTGGTGAAATCAGAGCTCTCCCCAACTTTGGTGAGGCCTCTGAACTT 
P.Glauca: CCGAGGGAGACGAGAAGAAGAGCGAGAGGAGAATCCATATGTATTCCACAGTGACAGCTTCCGGACCAGAGCATCATCTGAAGCTGGTGAAATCAGAGCTCTGCCGAACTTTGGGGAGGTCTCTGAACTT 
280 * 300 * 320 * 340 * 360 * 380 
CTTGAAGGGATTAG Af.~AT CAG.~GTTACCTGCATTGAAATGA ACCCAA ACGGT ATGCTCCCTCACTAT TTGA GCGACATGGAT TTATATGT?ACT GAGGAAGAGG7TAC.m.Gc TA G~GC 
L.Pine : CTTGAAGGGATTAGTAAATACAGAGTTACCTGCATTGAAATGAGACCCAACACGGTCATGCTCCCTCACTATCTTGACGCGACATGGATTTTATATGTTAC?GGAGGAAGAGGTTACATAGCTTACGTGC 
P.Glauca: CT?GAAGGGATTAGAAA.~T7CAGAGTTACCTGCATTGAAATGAAACCCAATACGGTGATGCTCCCTCACTATATTGATGCGACATGGATCTTATATGTTACTAGAGGAAGAGG7TACATAGCCTATGTGC 
400 * 420 * 440 * 460 * 480 * 500 * 520 
ACCAGAATGA CTGGT AAAAGAAAGTTGGAGGAAGGAGATGTATT GGTGTTCCAAGTGGTCATACATTTTATCTCGT7AACAACGATGACCA AACA CCTTCGCATT C AGTCTC TGCGT C GT 
L.PiJe : ACCAGAATGAACTGGTGAAAAGAAAGTTGGAGGAAGGAGATGTATTTGGTGTTCCAAGTGGTCATACATTTTATCTCGTTAACAf.CGATGACCACAACAGCCTTCGCATTACCAGTCTCCTGCGTACAGT 
P.Glauca: ACCAGAATGAGCTGGTTAAAAGAAAGTTGGAGGAAGGAGATGTATTCGGTGTTCCAAGTGGTCATACATTTTATCTCGTTAACAACGATGACCATAACACCCTTCGCATTGCTAGTCTCGTGCGTCCCGT 
540 * 560 * 580 * 600 * 620 * 640 
GTCTACG T CGAGGAGAATAT AGCCCT CTACGTTGC GGAGGTCGGAATCCT AGACTGTTTACTCTGCCTTTAGCGATGATGTTCTCGA GCTGCATTCAATACGAACGT A AG AGCT G.ri.AC 
L.Pine : GTCTACGATGCGAGGAGAATATGAGCCCTACTACGTTGCTGGAGGTCGGAATCCTGAGACTGTTTACTCTGCCTTTAGCGATGATGTTCTCGA.AGCTGCATTCAATACGAACGTTATAGAAGCTAGAACA 
P.Glauca: GTCTACGGTCCGAGGAGAATATCAGCCCTTCTACGTTGCGGGAGGTCGGAATCCTCAGACTGTTTACTCTGCCTTTAGCGATGATGTTCTCGAGGCTGCATTCAATACGAACGT-ACAGCAGCTTGAACG 
660 * 680 * 700 * 720 * 740 * 760 * 780 
ATTTTC GGTG ACA A AA GGAGTCATA TCCA G CAAATGAAGAACAGATTAGAGAAATG TGAGGAAACGGGGATTTTCAGCAG ATC ATGTCTGCA CTGAGCACCC .ri.AGCCTTT AACC 
L.Pine : CATTTTCCGGTGCACATAGAACGGGAGTCATATTCCATGGCAAATGAAGAACAGATTAGAGAAATGTTGAGGAAACGGGGATTTTCAGCAGJl.ATCCATGTCTGCATCTGAGCACCCAAAGCCTTTTJl4~cc 
? . G 1 a uca : TATTTTC -GGTGGArnCAAAAGTGGJl.GTCAT AATCCACG-CW TGAAGAACAGATTAGAGAAA TGATGAGGAAACGGGGATTTTCAGCAGG.~.TCTATGTCTGCACCTGAGCACCCCAAGCCTTTCAACC 
800 * 820 * 840 * 860 * 880 * 900 
TTCGGAACCAGAAGCCAGATTTCG.~GAACGA AATGGCAGGTTTACTA GCTGGTCCCAA A ATCCT TTCT GACGCG TCGA GTT C~G TGGG TTG CG TTTGAATCCTGGA CCATG/l.C 
L.Pine : TTCGGAACCAGAAGCCAGATTTCGAGAACGACAATGGCAGGTTTACTAGAGCTGGTCCCAATGAAAATCCTCTTCTTGACGCGGTCGATGTTACTGCTGGGTT7GGCGTTTTGAATCCTGGAACCATGAC 
P. Glaue a: TTCGGMCCAGAAGCCAGJl.TTTCGAGAACGAAAATGGCAGGTT~ACTATTGCTGGTCCCAAAAATTATCCTTTTCTAGACGCGCTCGACGTTTCTGTTGGGCTTGCCGATTTGAATCCTGGATCCATGJl.C 
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920 * 940 * 960 * 980 * 1000 * 1020 * 1040 
AGCCCCATCTC CAAC CGAAA CAAC TCAATCG CATTGT AC A GGGGA GGAAGGATTGAGATGGCGTGCCCGCACCTTGGTCAACATGG TGGTCTAGTC GCGCGAGA AGGCGA CA GA 
L.Pine : AGCCCCATCTCACAACACGAAAGCAACCTCAATCGCCATTGTCACACAGGGGGAGGGAAGGATTGAGATGGCGTGCCCGCACCTTGGTCAACATGGCTGGTCTAGTCGGCGCGAGAAAGGCGATCAGGAA 
P.Glauca: AGCCCCATCTCTCAACTCGAAATCAACGTCAATCGGCATTGTTACGAATGGGGAAGGAAGGATTGAGATGGCGTGCCCGCACCTTGGTCAACATGGTTGGTCTAGTCCGCGCGAGAGAGGCGACCAAGAT 
1060 * 1080 * 1100 * 1120 * 1140 * 1160 
ATTA TACCAGAG GT GGGCAA GCTGAG ACCGGCA CGTTTA TTGTTCCTGC GGTCATCCAATCACCGAGATAGCTT ACA A GCC CCT AAATCTTGTGGTTTGAT TTAATAC 
L.Pine : ATTAATTACCAGAGGGTACGGGCAAGGCTGAGAACCGGCACCGTTTACGTTGTTCCTGCAGGTCATCCAATCACCGAGATAGCTTGCACAGAGGGCCACCTTGAAATCTTGTGGTTTGATATTAATACGA 
P.Glauca: ATTACCTACCAGAGAGTCTGGGCAAAGCTGAGGACCGGCAGCGTTTATATTGTTCCTGCTGGTCATCCAATCACCGAGATAGCTTCAACAAACAGCCGCCTGCAAATCTTGTGGTTTGATCTTAATACCC 
1180 • 1200 * 1220 * 1240 * 1260 * 1280 * 1300 
GCGGCAACGAGAGACAATTCCTGGCAGGAAAG ACP.ATGTGCTT A ACG TGGAGA GGAG TCAGGCAG TATCCTTCAP,C TACCACGTGGGGAAGAG T GA GAAGT TT C G GCAAAAGGA 
L .Pine : GC GGCAACGAGP.GACAA TTCCTGGCAGGAAAGTACAA TG TGC TTCAAACGCTGGAGAAGGAGGTCAGGCAGATATC CTTCAACATACCACGTGGGGAAGAGCTGGATGAA GTTTTAC GGCGGCAAAAGGA 
P.Glauca: GCGGCAACGAGAGACAATTCCTGGCAGGAAAGAACAATGTGCTTAACACGTTGGAGAGGGAGATCAGGCAGCTATCCTTC.l\ACGTACCACGTGGGGAAGAGATTGAAGAAGTGTTGCAGGCGCAAAAGGA 
1320 * 1340 * 1360 * 1380 * 1400 * 1420 
TCAP.GTCATCCT AGAGG CCCCAA C AAG CG GACGAG C AGGAGCTCTTCTTAGATCCATG CATCATCGCAG TCGCAT ATGGACGACA GAC AGAGTTTCTC ACGTTCACTCTT A T 
L.Pine : TCAAGTCATCCTCAGAGGGCCCCAAATGCAAAGGCGAGACGAGCCAAGGAGCTCTTCTTAGATCCATGCCATCATCGCAGCTCGCATCATGGACGACAAGACTAGAGTTTCTCCACGTTCACTCTTTAGT 
P.Glauca: TCAAGTCATCCTGAGAGGCCCCCAACGACGAAGCCGGGACGAGGCGAGGAGCTCTTCTTAGATCCATGTCATCATCGCAGATCGCATTATGGACGACATGACAAGAGTTTCTCGACGTTCACTCTTP.A-T 
1440 * 1460 * 1480 * 1500 * 1520 * 1540 * 156~ 
ATCTACTTAA AATAAG TAT CATATATGAAGCCCAA AAATGTGTTCGAAGATGA CTC TT T TCT AATGAATGTAT TATGAGT T AACAAA CTATCGTTGGGCTCTTCTCTTGCTACTTCA 
L.Pine : ATCTACTTAAGAATAAGTTATGCATATATGAAGCCCAAAAAATGTGTTCGAAGATGAGCTCCTTTTATCTTAATGAATGTATATATGAGTTTCAACAAACCTATCGTTGGGCTCTTCTCTTGCTACTTCA 
P.Glauca: ATCTACTTP.AAAATAAGCTATCCATATATGAAGCCCAATAAATGTGTTCGAAGATGAACTCTTTCTGTCTAAATGAATGTATGTATGAGTCT-AACAAAGCTATCGTTGGGCTCTTCTCTTGCTACTTCA 
1580 * 
ATGA ATGGAATGC GATCTT 
L.Pine : ATGACATGGAATGCTGATCTT--------------
P.Glauca: ATGP.AATGGAATGCAGATCTTCTCTTAAAAAAAAA 
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ACTATAGGGCACGCGTGGTCGACGGCCCGGGCTGGTAAAAATTCATTTAC 
TAATCAAAACATGATGAGATTCATAACCAAAGTCTGTTATAAACCATGAT 
TATAACCAACAGATTAACAATGATAGAACAACCATTAAAACCACATAATA 
ACAAGTACATTTACACATGGAACACAAGAGGAAAATAGCTCTTATTAACA 
TATGAAAAATGTAACTAGGTCAAGGACTTCCACGCACCAACCAACCATAG 
ATTGGGCTGAACCAAATCTTTCTTTCAACTAATCACCCCTAAGCCATATT 
CCCAGCATGAATGTGGGACTTACAAAAAAACAAACAAGGATTCCTTAGGA 
TTTACCATAATCCACCAAGGGATTCCTAGGCCCAAGCCCTCATCTATACA 
ACTAGGATTTACTGCAATCCCACCAAGGGATTCCTAAGCCCAAACAAGAA 
ACACACACTACCAGGATTTAGATAAACCCCCTTTGTGGNGCTGCTATCAG 
CTNNGTTTCTTTTACCTTCTGNATATCTTCTGNGGACACCTGNCTTTANA 
AGCCGA TTCCACCNT 
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VICILIN-LIKE SEED STORAGE PROTEIN 
GENE PROMOTER AND METHODS OF 
USING THE SAME 
FIELD OF THE INVENTION 
5 
2 
message was not evident until later (day 10). Thus, both 
transcriptional and post-transcriptional events appear to be 
important in determining the protein complement of seed 
tissues. (Krochko et al., 1992). 
Superficially, somatic embryos mimic the developmental 
stages of zygotic seeds, i.e., the globular, heart, torpedo, and 
cotyledonary stages (Steward et al., Science, 143:20-27, 
1964). However, despite the gross morphological 
similarities, somatic embryos may exhibit other features 
The present invention relates to isolated vicilin-like gene 
promoters, promoter-gene constructs, methods of producing 
polypeptides in plants, methods of monitoring embryo matu-
rity of conifers, and plants per se. 
BACKGROUND OF THE INVENTION 
The expression of seed-storage protein ("SSP") genes in 
plants is induced during seed development and is restricted 
10 which suggest aberrant development, including truncated 
cotyledonary development, precocious germination, 
recallusing, multiple or fuse cotyledons, or inability to 
germinate (Ammirato, Bio/Technology, 1:68-74, 1983; 
15 
to the embryos. SSP gene expression takes place primarily 
in specialized storage cells located in the embryonic axis, 
cotyledons, and the endosperm of developing seeds 
(Goldberg et al., Cell, 56:149-160, 1989). Notably, SSP 
gene expression does not take place in mature vegetative 
20 
organs (Thomas, Plant Cell, 5:1401-1410, 1993). In 
Bapat et al., Plant Cell Rep., 7:538-541, 1988). 
Comparisons between somatic and zygotic embryos have 
shown that somatic embryos can accumulate SSPs (Crouch, 
Planta, 156:64-74, 1982; Shoemaker et al., Plant Cell Rep., 
6:12-15, 1987), and can also be induced to become desic-
angiosperms and gymnosperms, maximum accumulation of 
seed-storage proteins and abundant synthesis of oil and 
starch have been observed during mid to late embryo 
development. 
One example of SSP gene expression is the synthesis of 
the 2S protein, a seed storage protein encoded by a multi-
gene family which synthesis has been shown to be limited to 
the later stages of seed development. The expression of the 
2S protein has been correlated with the accumulation of 2S 
mRNA (Gander et al., Plant Mal. Biol., 16:437-448, 1991). 
Regulatory domains within plant promoters found to be 
necessary for specific expression patterns of SSPs have been 
determined using deletion and gain of function experiments 
in transgenic plants (da Silva et al., Plant J., 5:493-505, 
1994; de Parter et al., Plant Cell, 5:877-886, 1993; Kawa-
goe et al., Plant J., 5:885-890,1994; Lessard et al., Plant 
Mal. Biol., 22:873-885, 1993; Thomas et al., Plant Cell, 
2:1171-1180, 1990). Genes that regulate expression of SSPs 
represent an important model for the study of the mecha-
nisms of developmental-stage and tissue-specific gene 
expression. 
cation tolerant under appropriate culture conditions 
(Senaratna et al., Plant Sci., 65:253-259, 1989). However, 
few studies have been conducted on physiological and 
biochemical changes occurring in somatic embryogenesis in 
parallel with studies in zygotic embryogenesis. In particular, 
seed-specific storage proteins, because of their nature and 
25 abundance, are expected to be useful markers in the study of 
gene expression in embryogenic systems. 
SSP accumulation is thought to be temporally and spa-
tially regulated, primarily at the level of gene transcription 
30 (Muntz, Biochem. Physiol. Pflnazen, 182:93-116, 1987). This conclusion is based primarily on the absence of SSP 
mRNA in non-seed tissues, and the observed coincidence 
between the period of maximum seed storage protein syn-
thesis in developing seeds and mRNA accumulation, as 
35 determined by Northern blot (Walling et al., Proc. Natl. Acad. Sci. USA, 83:2123-2127, 1986). Factors which affect 
the accumulation of SSPs in somatic and zygotic embryos 
vary with the specific SSP, the developmental stage, the 
tissue (axis or cotyledon), and nutritional conditions (Muntz, 
40 Biochem. Physiol. Pflnazen, 182:93-116, 1987; Walling et 
al., Proc. Natl. Acad. Sci. USA, 83:2123-2127, 1986; Laden 
et al., Plant Physiol., 84:35-41,1987). The relative magni-
tude of each of these factors remains to be determined. The gene families that encode the main SSPs have been 
characterized in several plant species (Guerche et al., Plant 
Cell, 2:469-478, 1990; Higgins, Ann. Rev. Plant Physiol., 45 
35:191-221,1984;Panget al., Plant Mal. Biol., 11:805-820, 
1988). Seed-storage proteins have been classified into four 
different groups based on solubility. Albumins, which are 
water-soluble; globulins, which are salt-soluble; glutelins, 
which are soluble in acids, alkali ionic detergents, and 50 
urea-containing solutions; and prolamins, which are alcohol 
soluble. The glutelins and prolamins are the major forms of 
cereal SSPs while the globulins are the most prevalent class 
of SSPs in legumes and oats (Shotwell et al., The Biochem-
istry of Plants, Vol. 15: A Comprehensive Treatise, Aca- 55 
demic Press, San Diego, Calif., pages 297-345, 1989; Kro-
chko et al., Plant Physiology, 99:46-53, 1992). However, to 
date there has been no detailed study of the accumulation of 
seed-storage proteins and the qualitative and quantitative 
properties of seed-storage proteins in the majority of 60 
angiosperms and gymnosperms. 
A recent study showed a marked time differential between 
SSP synthesis and mRNA accumulation during development 
of zygotic and somatic embryos of alfalfa (Medicago sativa 
L.). Of three storage proteins studied (7S, llS, and 2S), 65 
mRNAfor the 2S protein was found early in somatic embryo 
development (day 3) but the protein associated with the 2S 
Many genes have been introduced into plants using a 
variety of genetic engineering techniques, sometimes using 
regulatory elements from sources other than the target plant. 
Often, the gene coding for the desired polypeptide is placed 
under the control of a constitutive promoter allowing the 
expression of the desired polypeptide in the plant throughout 
the entire life of the plant, irrespective of the plant's devel-
opmental stage. For example, the 35S promoter from Cau-
liflower Mosaic Virus (CaMV) has been used extensively for 
constitutive expression of heterologous genes. 
For some applications, however, it is not necessary to 
continuously express the desired polypeptide throughout the 
life of the plant. In these instances, it is desirable to limit the 
expression of the desired polypeptide to specific instances, 
often linked to the stage of plant development. It is often 
useful to control the time when the desired polypeptide is to 
be expressed through the use of inducers. In some situations, 
it is desirable to maintain baseline expression of a desired 
polypeptide while allowing over-expression of the desired 
polypeptide at certain times. 
While current compositions and methods may be effective 
to deliver certain genes to plants, there is a need for 
improved compositions and methods. There is a need for an 
inducible promoter that will allow the expression of a 
US 6,462,257 Bl 
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desired polypeptide. There is also a need for a method of 
transforming a target plant with a DNAconstruct comprising 
an inducible promoter operatively linked to one or more 
genes coding for desired polypeptides. There is a further 
need for a method of assessing the developmental maturity 5 
of plant embryos. 
4 
FIG. 5 depicts the alignment of Loblolly pine vicilin-like 
cDNA (SEQ ID NO: 16) and Picea glauca vicilin-like 
cDNA. (SEQ ID N0:7) 
FIG. 6 depicts a gel showing the presence of vicilin gene 
transcripts in different stages of somatic embryogenesis. 
Lanes 4--9 represent stages 4-9, respectively. 
SUMMARY OF THE INVENTION 
The present invention is directed to isolated promoters 
comprising novel nucleic acid sequences. The promoter is a 
vicilin-like seed storage gene sequence and may be a nucleic 
acid sequence selected from the group consisting of SEQ ID 
NO:l, SEQ ID NO: 2, SEQ ID N0:3, SEQ ID N0:4, SEQ 
FIG. 7 depicts vicilin gene expression in late zygotic 
embryos. An RT-PCR reaction was carried out with vicilin 
primers, which produced 1.4 Kb fragments of the vicilin 
10 gene. Columns A-J represent stages 9.1-9.10, respectively. 
Column K represents a 1 Kb ladder. 
ID N0:5 and SEQ ID N0:6. The isolated promoter of the 
present invention includes a fragment thereof having sub-
stantially the same activity. 
FIG. 8 depicts a Southern blot hybridization with the 
vicilin gene. Lane 1 represents tomato genomic DNA. Lane 
15 2 represents Loblolly pine genomic DNA Lane 3 represents 
a 1 Kb ladder marker. 
Another embodiment of the present invention is a con-
struct of the promoter operably linked to a desired gene. 
Also provided by the present invention is a nucleic acid 
sequence having the functional properties of the promoter of 20 
the present invention, the complement of which hybridizes 
under stringent conditions to the nucleic acid sequence of 
the promoter. 
The present invention is also directed to methods of 
25 expressing a desired polypeptide in a plant, the method 
comprising preparing a construct of a vicilin-like gene 
promoter sequence operably linked to a desired gene, 
thereby producing a promoter-gene construct, and trans-
forming a plant with the promoter-gene construct which 
30 thereby ultimately expresses a desired polypeptide in the 
plant. Typically, the polypeptide is a SSP or a structural 
protein. The desired gene may heterologous or non-
heterologous and may be a reporter gene, according to the 
present invention. The method of expressing a desired 
35 polypeptide may include constitutive or induced expression 
of the desired gene. Suitable inducers include abscisic acid 
(ABA), heat, and light. 
Yet another embodiment of the present invention is a 
method of monitoring embryo development in conifers, the 40 
method comprising preparing a construct of a vicilin-like 
gene promoter sequence operably linked to a reporter gene, 
thereby producing a promoter-gene construct; and trans-
forming an embryo with the construct, wherein the expres-
sion of the reporter gene is indicative of the degree of 
45 
activation of the vicilin-like gene promoter thereby provid-
ing a qualitative marker of embryo development that may be 
monitored. 
FIG. 9A depicts the effect of heat as an inducer on vicilin 
gene expression. 
FIG. 9B depicts the efficiency of transfer from the gel to 
the blotting media. 
FIG. 10 depicts the effect of different concentrations of 
ABA as an inducer of vicilin gene expression. From left to 
right, 0.0 µM, 0.1 µM, 1.0 µM, and 10.0 µM ABA were 
added to the samples. 
FIG. 11 depicts the sequence of a fifth promoter (SEQ ID 
N0:5) isolated from loblolly pine. 
DESCRIPTION OF PREFERRED 
EMBODIMENTS 
The present invention is directed to vicilin-like gene 
promoters including nucleic acid sequences thereof. The 
vicilin-like gene promoters were isolated from Loblolly pine 
genes encoding vicilin-like SSPs. As used herein, the term 
"vicilin-like" refers to proteins (and polypeptide sequences 
and nucleic acids encoding therefor) that are SSPs substan-
tially similar to the SSPs found associated with the seeds of 
leguminous plants. Similarly, vicilin-like promoters are pro-
moters of genes encoding the above mentioned proteins. 
As used herein, the term "promoter" refers to a nucleic 
acid sequence that directs the transcription of a gene. 
Typically, a promoter is located in the 5'region of a gene and 
is proximal to the transcriptional start site of the gene. 
Promoters of the present invention are from about 100 to 
about 600 nucleotides in length. In a preferred embodiment, 
the promoters are from about 200 to about 400 nucleotides 
in length. In a more preferred embodiment, promoters are 
about 340 nucleotides in length. The present invention 
includes six vicilin-like gene promoter sequences, including The present invention is also directed to transgenic plants, 
including transgenic plants comprising a vicilin-like gene 
promoter operably linked to a desired gene. The plant may 
be an angiosperm or gymnosperm, preferably a conifer. 
50 SEQ ID NO:l, SEQ ID N0:2, SEQ ID N0:3, SEQ ID N0:4, 
SEQ ID N0:5, and a predicted consensus sequence of SEQ 
ID NOS: 1-4, SEQ ID N0:6. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 depicts the alignment of four promoters isolated 
from loblolly pine (SEQ ID NOS: 1-4) and the predicted 
consensus sequence (SEQ ID N0:6) of SEQ ID NOS: 1-4. 
FIG. 2 depicts the sequence of vicilin cDNA (SEQ ID 
N0:16) from loblolly pine. Initiator and termination codons 
are marked in bold. A polyadenylation-like sequence in the 
3'untranslated region is also marked in bold. 
FIG. 3 depicts the loblolly pine vicilin-like SSP amino 
acid sequence (SEQ ID NO:l 7). 
FIG. 4 depicts the amino acid alignment of vicilin-like 
proteins from loblolly pine (SEQ ID NO:l 7) and Picea 
glauca (SEQ ID N0:18), as well as the predicted consensus 
sequence. 
All or part of the vicilin-like promoter may be used to 
express a sequence or gene in accordance with the present 
55 invention. All or part of the vicilin-like promoter may be 
operably linked with a nucleic acid sequence or gene encod-
ing a protein to direct the expression of the sequence or gene. 
A portion, a part, a fragment, or the like, refers to one or 
more groups of nucleic acids within the vicilin-like promoter 
60 which control the expression of sequences that are operably 
linked to the promoter. "All", "part", and nucleic acid 
sequences which are "substantially similar" to the nucleic 
acid sequence of the vicilin-like promoter, for purposes of 
the present invention, means a nucleic acid molecule the 
65 sequence of which is preferably 25%, preferably 50%, more 
preferably 75%, and most preferably 100% identical to that 
of the vicilin-like promoter. The portion of the vicilin-like 
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promoter sequence may be in a single consecutive 
arrangement, or more than one arrangement of consecutive 
nucleic acids. In addition, the present invention includes 
sequences which are substantially similar to the sequences 
of SEQ ID NOS: 1, 2, 3, 4, 5, 6, or portions thereof. 
Substantially similar, for purposes of the present invention is 
a sequence which is preferably 25%, preferably 50%, more 
preferably 75%, and most preferably 100% identical to SEQ 
ID NO:l, 2, 3, 4, 5, or 6. All or part of SEQ ID NOS: 1, 2, 
6 
size, whether or not glycosylated, phosphorylated or modi-
fied post-translationally. Examples of "polypeptides" con-
templated by the instant invention include amino acids, 
proteins and peptides. "Desired polypeptides" refer to 
5 polypeptides encoded by a desired gene, and that may be the 
result of a promoter-gene construct of the present invention, 
including polypeptides that are functionally equivalent or 
that are fragments of the polypeptides or selected polypep-
tides. 
3, 4, 5, or 6 may be used to express a sequence or gene 10 
operably linked thereto. 
According to the present invention, methods of express-
ing polypeptides in a plant are provided. Such methods 
comprise constructing an expression vector construct com-
prising a vicilin-like gene promoter operably linked to a 
desired gene and administering the construct to the plant. At 
least one gene encoding a desired polypeptide may be 
The vicilin-like gene promoter may be a functional 
equivalent of any of the nucleic acid sequences set forth in 
SEQ ID NOS: 1, 2, 3, 4, 5, or 6. As used herein, the term 
"functional equivalent" refers to any nucleic acid sequence 
which is complementary to a reference nucleic acid 
sequence which, under stringent conditions, will hybridize 
with the reference sequence and has activity similar to the 
vicilin-like gene promoter. 
As used herein, the term "stringent hybridization condi-
tions" are those in which hybridization takes place at 65° C. 
in 2.Sxsaline citrate buffer (SSC) followed by a rinse step at 
37° C. in a reduced buffer concentration. 
As used herein, the term "percent homology" relates to 
the ratio of the identical nucleotides when two sequences are 
compared to the total number of nucleotides when the 
sequences are aligned. Sequence alignments for both DNA 
and proteins were performed using the National Center for 
Biotechnology Information's BLAST utility program using 
default settings. 
Other embodiments of the present invention are con-
structs which include, but are not limited to, nucleic acid 
sequences including DNA, cDNA, genomic DNA, RNA, 
mRNA, tRNA, suitable nucleic acid sequences such as the 
sequences set forth in SEQ ID NOS: 1, 2, 3, 4, 5, 6, and 
conservative alterations in such nucleic acid sequences 
including additions, deletions, mutations, and homologues. 
The sequences within the scope of the present invention 
include antisense sequences which may alter plant 
characteristics, including those identified above. Antisense 
sequences may prevent the translation of certain sequences 
in plants. Inhibition of expression of certain sequences, such 
as those responsible for the characteristics identified herein, 
may be achieved with antisense sequences. 
15 administered to a plant; however, more than one gene 
encoding desired polypeptides may be administered to a 
plant in accordance with the methods of the present inven-
tion. The nucleic acid sequence that encodes the polypeptide 
is operably linked to regulatory elements e.g., a vicilin-like 
20 gene promoter) necessary for expression of the sequence in 
the plant. 
As used herein, the term "administration" refers to the 
mechanism of supplying the expression vector comprising a 
vicilin-like gene promoter and at least one desired gene to a 
25 target plant. Methods of administration of expression vec-
tors to plants are known to those of skill in the art. According 
to some embodiments of the invention, the expression vector 
is administered to the target plant by infection with Agro-
bacterium. One method known in the art for administering 
30 the expression vector to a plant is the use of a gene gun. 
Electroporation and microinjection may also be used to 
introduce expression vectors into the target plant. 
Administration to a plant may comprise transforming the 
plant with the promoter-gene construct. An expression 
35 vector, comprising a vicilin-like gene promoter operably 
linked to at least one desired gene, may be used to achieve 
transformation of a plant. As used herein, the term "expres-
sion vector" refers to the molecules that comprise a nucleic 
acid sequence which encode one or more desired polypep-
40 tides and which include initiation and termination signals 
operably linked to regulatory elements including a promoter 
and polyadenylation signal capable of directing expression 
in the plant to be treated. Initiation codons and stop codons 
are generally considered to be part of a nucleic acid 
45 sequence that encodes a polypeptide. However, it is neces-
sary that these elements be functional in the cells of the plant 
to which the gene construct is administered, e.g., the initia-
tion and termination codons are in frame with the coding 
sequence. Administration to the desired plant may be per-
As used herein, the term "desired gene" refers to a nucleic 
acid sequence which encodes a desired polypeptide. Accord-
ing to the instant invention, "desired genes" include, but are 
not limited to, SSP genes, structural genes, insecticidal 
toxins, herbicide resistance genes, drought tolerance genes, 
anti-microbial genes, anti-fungal genes, anti-viral genes, 
genes encoding regulatory proteins, and genes encoding 
enzymes involved in metabolic pathways. While the term 
"gene" is used throughout the specification to define the 
sequence operably linked to a vicilin-like promoter, "gene" 55 
includes any sequence that has substantially the same activ-
50 formed in conjunction with agents which facilitate the 
uptake and/or expression of the desired gene by the target 
plant. Such agents include but are not limited to polyethyl-
ene glycol, heat treatment of cells, and cold treatment of 
cells. 
Desired genes within expression vectors administered to 
a plant embryo are expressed under control of the vicilin-
like gene promoter, producing the desired polypeptide. Typi-
cal expression vectors include, but are not limited to, the pBl 
series of vectors and derivatives thereof, and green fluores-
cent protein reporter systems. Other methods of delivering 
sequences into plants are known in the art, including and not 
ity as the desired gene. One measure of "substantially the 
same activity", for example, is a functioning polypeptide or 
protein resulting from a nucleic acid sequence operably 
linked to a vicilin-like promoter of the present invention. 60 
Accordingly, all or part of a gene is included in the definition 
of"desired gene". The definitions set forth above to describe limited to Ti-plasmid vectors, in vitro protoplast 
transformation, plant virus-mediated transformation, 
liposome-mediated transformation, gene gun, and ballistic 
all or part of the vicilin-like promoter are applicable to a 
desired gene as well. The desired genes may be heterologous 
or non-heterologous. 65 particles. 
As used herein, the term "polypeptide" refers to any 
translation product of a nucleic acid molecule, regardless of 
Target plants to be used in accordance with the present 
invention are all species of higher and lower plants of the 
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Plant Kingdom. Plant embryos, seedlings, and seeds are 
included in the scope of the invention. The vicilin-like 
promoter-gene constructs are useful in plants, plant parts, 
seeds, and plant culture. A mature plant includes a plant at 
any stage in development beyond the seedling. A seedling is 5 
a very young, immature plant in the early stages of devel-
opment. 
8 
by the vicilin-like promoter in such transgenic embryos. 
Such phenotypic changes provides a means to assay for 
embryos having reached a particular stage of development. 
Also embodied by the present invention is a "transgenic 
plant" that refers to a target plant comprising one or more 
constructs of a vicilin-like gene promoter linked to a desired 
gene. 
The present invention contemplates target plants 
including, but not limited to, gymnosperms including and 
not limited to conifers such as evergreens, trees and shrubs, 
cycads, oaks, gumwoods, aspens, cottonwoods; 
angiosperms including but not limited to, annuals, 
perennials, monocotyledons, and dicotyledons; and the like. 
A further aspect of the methods of expressing a desired 
polypeptide in a plant optionally includes inducing expres-
sion of the desired gene with a suitable inducer. The vicilin-
like gene promoter is induced by an agent, i.e., an inducer, 
that initiates transcription, or increases the rate of 
transcription, of a desired gene. Inducers contemplated by 
the instant invention include, but are not limited to, abscisic 20 
acid, heat, light, and other endogenous signals. Abscisic 
acid, in accordance with the present invention, includes 
amounts of abscisic acid not typically found in plants in 
under natural conditions. For example, in loblolly pine, 
abscisic acid from about 0.001 µM to about 10 µM can be 25 
used as an inducer. Heat, in accordance with the present 
invention, includes temperatures not typically existing for 
plants growing under natural conditions. For example, in 
loblolly pine, heat, from about 30° C. to about 50° C. can be 
Depending upon the nature of the polypeptide produced 
according to the instant invention, various aspects of the 
10 present invention, such as those set forth below, can be 
exploited. For example, if the polypeptide encoded by the 
desired gene is a reporter gene, the expression of the 
polypeptide in the desired plant provides methods of assess-
ing promoter activity. If the polypeptide encoded by the 
15 desired gene is a SSP, the expression of the polypeptide 
provides increased amounts of SSP. 
used as an inducer. 30 
Yet another embodiment of the instant invention provides 
a method of monitoring embryo development in plants, 
including, but not limited to conifers. The methods of 
monitoring embryo development include assessing the 35 
maturity of seed embryos. One embodiment of the method 
comprises administering to a target plant a vicilin-like gene 
promoter operably linked to at least one reporter gene, and 
transforming an embryo with that construct. Upon uptake by 
the target plant, the plant's cells express the reporter gene. 40 
The expression of the reporter gene under the control of the 
vicilin-like gene promoter is indicative of the degree of 
activation of the vicilin-like gene promoter and thereby 
provides a quantitative marker of embryo development that 
may be monitored. 45 
As used herein, the term "reporter gene" refers to genes 
and polypeptides encoded thereby, that are used to monitor 
gene expression, and, in some cases to allow protein local-
ization in cells. Reporter genes include, but are not limited 
to, green fluorescent protein (GFP), alkaline phosphatase, 50 
chloramphenicol acetyltransferase, B-glucuronidase (GUS), 
firefly luciferase, bacterial luciferase and ~-galactosidase. In 
a preferred embodiment, the reporter gene encodes GUS. In 
a more preferred embodiment, the reporter gene encodes 
green fluorescent protein. 55 
The stage of development of a conifer or other plant 
embryo can be evaluated by monitoring the expression of a 
reporter gene functionally linked to a promoter. A non-
limiting example of such a promoter is the vicilin-like gene 
promoter. The reporter gene will only be expressed when the 60 
vicilin-like promoter is induced, an event that is coupled to, 
and therefore an indicator of the maturity of the embryo. The 
appearance of an easily assayable phenotype, characteristic 
of the reporter protein, such as color production in an assay, 
fluorescence of embryos, or the ability of an embryo to grow 65 
in the presence of a particular chemical, is dependent on 
expression of the reporter gene, which is in turn controlled 
The following examples are meant to illustrate the inven-
tion and are not intended to limit the scope of the invention 
in any way. Those skilled in the art will recognize modifi-
cations that are within the spirit and scope of the invention. 
All references cited herein are hereby incorporated by 
reference in their entirety. 
EXAMPLES 
Example 1 
Cell Cultures, RNA Preparations, and Vicilin-like 
Genes 
Cell suspension culture BC#260, comprising early stage 
embryos and undifferentiated cell mass, was grown in 
embryo maintenance media (Medium 16, see Table 1). The 
culture was subcultured weekly into embryo maturation 
media (Medium 240, see Table 1) for Loblolly pine embryos 
(stages one to nine). Both Medium 16 and Medium 240 are 
described by Pullman et al.(TAPPI R&D Division Biologi-
cal Sciences Symposium, Oct. 3-6, 1994, Minneapolis, 
Minn., 31-34). 
TABLE 1 
Media compositions for liquid maintenance (16), 
and development and maturation media (240). 
Components (mg/l) Media 16 Media 240 
NH4 N03 603.8 200 
KN03 909.9 909.9 
KH2 P04 136.1 136.1 
Ca(N03 ) 2 .4H20 236.2 236.2 
MgS04 .7H2 0 246.5 246.5 
Mg(N03)o.6H20 256.5 256.5 
MgC12 .6H2 0 101.7 101.7 
KI 4.15 4.15 
H3 B03 15.5 15.5 
MnS04 .H20 10.5 10.5 
ZnS04 .7H20 14.4 14.4 
Na2 Mo04 .2H2 0 0.125 0.125 
CuS04 .5H20 0.125 0.125 
CoC12 .6H20 0.125 0.125 
FeS04 .7H20 6.95 13.9 
Na2 EDTA 9.33 18.65 
Maltose 0 20000 
Sucrose 30000 0 
PEG 8,000 0 130000 
myo-Inositol 1000 20000 
Casamino acids 500 500 
L-Glutamine 450 450 
Thiamine.RC! 1 1 
Pyridoxine.HCl 0.5 0.5 
Nicotinic acid 0.5 0.5 
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TABLE 1-continued 
Media compositions for liquid maintenance (16), 
and development and maturation media (240). 
Components (mg/l) Media 16 Media 240 
Glycine 2 2 
2,4-D 1.1 0 
BAP 0.45 0 
Kine tin 0.43 0 
ABA 0 5.2 
Gelrite 0 2500 
pH 5.7 5.7 
Cell suspension culture BC#260 was then treated with 3 
different concentrations of abscisic acid (ABA); 0.1 mM, 1 
mM, and 10 mM added to the embryo maintenance media. 
Treatments were over a period of four days. Cultures were 
incubated at room temperature with constant shaking. Treat-
ment was performed on cells from the end of the seven-day 
growth cycle (early log phase of cell division.) 
A three day old cell suspension culture #BC260 was used 
for heat treatment. Four equal aliquots, each of 20 mL of cell 
culture, were grown in a 37° C. shaking incubator for 0, 6, 
15 and 15+(drying time) hours. RNA was isolated from each 
aliquot after each time course. 
5 
10 
the center portion of the protein sequence. The amino 
terminus of the vicilin-like SSP shows less homology 
between each of the types of vicilin-like SSPs compared 
than at the carboxy terminus. 
Example 2 
Embryo Collection and Preparation 
Loblolly pine cones were collected weekly from Boise 
10 Cascade's breeding orchard near Lake Charles, Louisiana. 
The cones were shipped on ice and received within 24-48 
hours of collection. Cones were opened and seeds collected 
for isolation of embryos. Seeds were cracked using a 
hemostat, pried open with a scalpel, and the integument and 
15 nucellus tissue removed from the ovule. The female game-
tophyte was slit, pried open, and the dominant embryo/ 
embryos or mass was removed. Embryos were evaluated for 
stage using a dissecting microscope. Stage 9 embryos were 
further characterized by the week they were collected. For 
20 example stage 9.1 refers to stage 9 embryos, collected week 
1. Staged embryos were placed in cryostorage vials which 
were partially immersed in liquid nitrogen. Twenty similar 
stage embryos were collected and stored per vial. Frozen 
embryos were stored at - 70° C. until further analysis was 
25 desired. 
RNA was isolated using modifications of the methods of 
Sambrook et al. (Molecular Cloning, A Laboratory Manual, 
Cold Spring Harbor Laboratory Press, NY, 1989) and Kro-
chko et al. (Plant Physiol., 99:46-53, 1992). Cell suspen- 30 
sions and embryos were ground in extraction buffer ( 45% 
guanidium HCl, 10 mM EDTA, 2.5% Sarkosyl, 1 % 
~-mercaptoethanol, and 50 mM Tris-HCl (pH 7.6). A ratio of 
0.5 mL of extraction buffer to 0.1 g tissue was used. An equal 
volume of preheated phenol/chloroform/isoamyl alcohol 35 
(25:24:1) was added to the homogenate. After centrifugation 
Example 3 
Somatic Embryo Development and Vicilin-Like 
Promoters 
Cultures of somatic embryos from loblolly pine may be 
initiated as described by Becwar et al. (Can. J For. Res., 
1990, 20:810) or by other commonly known techniques. 
Somatic embryos were grown in cell suspension culture 
medium 16 and maturation medium 240. Resulting somatic 
embryos were stored at - 70° C. until needed. at 5000 g for 10 minutes at room temperature, the superna-
tant was collected and extracted with an equal volume of 
chloroform/isoamyl alcohol (24:1). The RNA was precipi-
tated by adding an equal volume of chilled isopropanol to 40 
the supernatant, collected by centrifugation, washed with 
70% ethanol, and dried under vacuum. The dried pellet was 
resuspended in lxTE buffer (1 mM EDTA, 10 mM Tris-
HCl( pH 7.5)) and re-precipitated by adding lithium chloride 
RNA was obtained from cell suspension culture and 
somatic and zygotic embryos as described above and then 
fractionated by electrophoresis on a 1.2% agarose gel in the 
presence of formaldehyde and 10 mM sodium phosphate 
(pH 7.4)(Ausubel et al., Current Protocols in Molecular 
Biology, 1989, 231-233, John Wiley & Sons, New York). 
RNA was transferred to a positively charged Qiabrane 
membrane (Qiagen Corp., Chatsworth, Calif.) and hybrid-
ized with a nick translated 32P probe having the sequence of 
to a final concentration of 2M. The pellet was resuspended 45 
in lxTE buffer, and the RNA reprecipitated by adding 0.2 
volumes of sodium acetate (pH 5.0) and 2.5 volumes of 
ethanol. 
SEQ ID N0:19, excised from pRP37 using EcoRI. Plasmid 
pRP37 was the product of cloning the Loblolly pine vicilin 
cDNA(SEQ ID N0:16) into pCR2.1 (Invitrogen, Carlsbad, The Loblolly pine vicilin gene when transcribed produces 
a transcript of about 1.6 kB and the Loblolly pine vicilin 
seed storage polypeptide consists of about 523 amino acids 
(SEQ ID NOS 16 and 17; see FIGS. 2 and 3). Sequence 
homology searches were done with Picea glauca mRNA for 
vicilin-like storage protein emb (X63191) PGVICSP, SEQ 
ID N0:7, (Braun et al., Plant Malec. Bio., 31:35-44, 1996), 
and Zamia furfuracea mRNA for vicilin-like SSP emb 
(Z50791) ZFVICLN7S, SEQ ID N0:8, (Newton et al., Plant 
Mal. Biol., 20:315-322, 1992.) Sequence homology was 
determined using the National Center for Biotechnology 
Information's BLAST utility program, using default param-
eters. 
The vicilin-like SSP gene from Loblolly pine has high 
nucleic acid homology (87%) with Picea glauca vicilin-like 
SSP gene, and 60% homology to Zamia furfuacea vicilin-
like SSP gene. Neighbor joining analysis of the amino acid 
sequences of vicilin-like SSPs of various species demon-
strates significant homology between species, especially in 
50 Calif.). The blot was hybridized with the probe (107 cpm/mL 
hybridization buffer) for 16 hours at 65° C. in the presence 
of 1 % BSA, 1 mM EDTA, 5% SDS, sonicated salmon sperm 
DNA, and 0.5 M sodium phosphate buffer (pH 7.2). The 
filters were washed twice (30 min. each) at 60° C. with wash 
55 buffer containing 0.5% BSA, 5% SDS, 1 mM EDTA, and 40 
mM sodium phosphate (pH 7.2). Two final washes were 
performed in a buffer containing 1 % SDS, 1 mM EDTA, and 
O.lxSSC at room temperature. To assess transfer efficiency, 
the same filters were hybridized with a probe (18S ribosomal 
60 RNA) constitutively expressed in Loblolly pine. A 0.5 Kb 
probe was excised from plasmid pRP18 with EcoRI for this 
purpose. Plasmid pRP18 was the product of cloning the 18S 
ribosomal DNA into pCR2.1 (Invitrogen, Carlsbad, Calif.). 
After drying, the filters were exposed to X-ray film (Kodak 
65 X-OMAT, Kodak, Rochester, N.Y.). 
CsCl purified Loblolly pine DNA and tomato DNA were 
subjected to Southern hybridization. Genomic DNA was 
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digested overnight with EcoRI and BamHI, separated by 
electrophoresis. A 1 Kb ladder (Promega, Madison, Wis.) 
was used as a molecular size marker. The digested DNA was 
transferred to Qiabrane nylon membrane (Qiagen, 
Chatsworth, Calif.) according to Sambrook et al., 5 
(Molecular Cloning, A Laboratory Manual, Cold Spring 
Harbor Laboratory Press, NY, 1989). Blots were hybridized 
with a radiolabeled probe consisting of the 1.4 Kb vicilin 
gene fragment from plasmid pRP37 following the protocol 
of Church et al., (Proc. Nat'l. Acad. Sci. USA 1984, 81: 
10 1991-1995) in a buffer containing 0.5 M sodium phosphate, 
5% SDS, 10 mM EDTA (pH 7.2). Blots were then washed 
in the same buffer diluted 1:10. Probes were prepared 
according to the directions for the random primer labeling 
kit (Pharmacia, Piscataway, N.J.). 
12 
column from the Plant RNA easy kit (Qiagen, Chatsworth, 
Calif.). One microgram of total RNA from each embryo 
developmental stage was used to prepare cDNA for the 
subsequent RT-PCR. Oligo dT18, dNTPs, and MLV Reverse 
transcriptase was obtained from Clontech, Palo Alto. The 
reverse transcription reaction was incubated at 42° C. for 
one hour. Ten microliters of cDNA product was used for the 
RT-PCR reaction. Using SEQ ID N0:14 and SEQ ID 
N0:15, a 1.4 Kb gene fragment was amplified from the 
RT-PCR template following the manufacturer's instructions. 
Forward 
5'-GAGACGAGAAGAAGAGCGAGAG-3' 
N0:14) 
primer: 
(SEQ ID 
Reverse primer: 
5'-TGAAGTAGCAAGAGAAAGAGCCC-3' (SEQ ID 
N0:15) 
Several PCR fragments containing the vicilin gene were 15 
isolated using degenerate primers specifically designed to 
amplify developmentally regulated genes. From these 
clones, the most distal fragment sequences were used to 
prepare forward and reverse primers in order to obtain a 
maximum length (about 111.SKb) vicilin cDNA. 20 Forward and reverse primers from 18S ribosomal RNA were 
used to verify the presence and amount of template for each 
RT-PCR reaction. (Quantum RNA 18S PCR Primers, 
Ambion, Austin, Tex.). 
Forward primer: 
5'-GAGACGAGAAGAAGAGCGAGAG-3'(SEQ ID NO: 
9) (DGfor) 
Reverse primer: 
5'-TGAAGTAGCAAGAGAAGAGCCC-3'(SEQ ID NO: 25 
10) (DGback) 
A 400 bp vicilin gene fragment was isolated from stage 8 
zygotic embryos using PCR primers SEQ ID NOS: 9 and 10, 
above. From this fragment, the full length vicilin gene and 
cis regulatory elements (promoters) were isolated. A cDNA 30 
library from zygotic embryos was prepared using a cap 
finder PCR cDNA library construction kit (Clontech, Palo 
Alto, Calif.). The cDNA library consisted of 2.5xl06 inde-
pendent clones in Lambda gt 11 vectors. Sixty thousand 
Lambda clones from the library were screened with the 400 35 
bp Loblolly pine vicilin fragment. Missing 3' sequences 
were obtained using the 3'RACE system (Gibco-BRL, Cat. 
No. 18373-019, Rockville, Md.). The gene specific primer 
used in the 3' RACE reaction was as follows: 
5'-ACATGGTTGGTCTAGTCCGC-3' (SEQ ID NO:ll) 40 
3' race (Genosys Biotechnologies, The Woodlands, Tex.) 
The promoter library was constructed using the Universal 
Genome Walker kit (Clontech, Palo Alto, Calif.). High 
molecular weight Loblolly pine genomic DNA was isolated 
from a fresh cell suspension culture 3 days after sub- 45 
culturing to new media using cell line BC #260, following 
the directions of Ausubel et al. Except Pvull, other enzymes 
digested the genomic DNA well. Primers were designed 
using Primer, Version 0.5 (Whitehead Inst. Of Biomedical 
Studies at MIT, Boston, Mass.). The following primers were 50 
used as gene specific primers for promoter screening: 
Initial isolation ofvicilin-like seed storage gene was from 
stage 8 Loblolly pine zygotic embryos. Several degenerate 
primers were prepared to isolate developmentally regulated 
genes including MAD box like genes from Loblolly pine. 
Because of the high abundance of SSP transcripts in 
embryos, the Vicilin-like seed storage gene was isolated. In 
order to isolate the Vicilin-like seed storage gene, cDNA 
libraries from stage 3, 4, 5, 6, 7, 8 and 9 of Loblolly pine 
zygotic embryos were prepared using cap finder PCR cDNA 
library construction kits ( Clontech, Palo Alto, Calif.). 
Example 5 
Delivery of Constructs to Plants and Monitoring 
Embryo Development 
A plant embryo is transformed with a construct of a 
vicilin-like promoter operably linked to the gene encoding 
green fluorescent protein (or other reporter genes) using 
techniques as described in Miki et al., "Procedures for 
Introducing Foreign DNA into Plants", in Methods in Plant 
Molecular Biology and Biotechnolgy, Eds. BR Glick, JE 
Thompson, CRC Press, Inc. 1993. Constructs can also be 
delivered to plant embryos, especially to Loblolly pine, 
using the techniques described in Wenck et al., Plant 
Molecular Biology 39 (3):407-416 (1999). 5'-CGTAGACCACTGTACGCAGGAGACTGGTAA 
TG-3'; (SEQ ID N0:12) (Gspprol); 
5'-CTCCTTCCTCCAACTTTCTTTTCACCAGTTC-3'; 
(SEQ ID N0:13) (Gsppro2) 
The development of the embryo is assessed by monitoring 
55 levels of green fluorescent protein (or other reporter gene 
products) using a microscope or other appropriate reporter 
gene product detection means. 
Modifications were made to the manufacturers' instruc-
tions for use of the Universal Genome Walker kit. The first 
seven cycles of Touch Down PCR for primary and second-
ary PCR were performed at 75° C. The desired PCR 
products, putative promoter fragments, SEQ ID NOS: 1-5, 60 
were gel purified and cloned into TA cloning vector 2.1 
(Invitrogen, Carlsbad, Calif.), according to the manufactur-
er's protocol. Putative promoters pRP 5.1, pRP 5.2, pRP 5.3, 
pRP 5.4 and pRP 5.5 were sequenced using M13 forward 
and reverse primers located in the TA cloning vector 2.1. 
RNA extraction was performed as described above. An 
extra step of RNA purification was performed using a 
The disclosures of each patent, patent application and 
publication cited or described in this document are hereby 
incorporated herein by reference, in their entirety. 
Various modifications of the invention, in addition to 
those described herein, will be apparent to those skilled in 
65 the art from the foregoing description. Such modifications 
are also intended to fall within the scope of the following 
claims. 
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SEQUENCE LISTING 
<160> NUMBER OF SEQ ID NOS: 19 
<210> SEQ ID NO 
<211> LENGTH: 341 
<212> TYPE: DNA 
<213> ORGANISM: Pin us taeda 
<400> SEQUENCE: 
actatagggc acgcgtggtc gacggcccgg gctggtaaaa gtgtgtgttt gcagggtgca 60 
gataatggca gcatgtatga cattagacat atggcattgg caaatgctgt cgattttggc 120 
actcatcact gtaattgttg caacatgtca atcgtctgca acatgccctg gtgatcatag 180 
gttatgcaag aactcagacg tgttcaccat tcttcaatac catatgcctc ttctgtctgg 240 
ttgcttccac cacgcgtcca tgcatgtgca tgattctctt gtatataaaa gtcccccttg 300 
cccattctgt ctagtaccgg acttcaccaa agcaccatca g 341 
<210> SEQ ID NO 2 
<211> LENGTH: 341 
<212> TYPE: DNA 
<213> ORGANISM: Pin us taeda 
<400> SEQUENCE: 2 
actatagggc acgcgtggtc gaggcccggg ctggtaaaag tgtgtgtttg cagggtgcag 60 
ataatggcag catgtatgac attagacata tggcattggc aaatgctgtc gattttggca 120 
ctcatcactg taattgttgc aacatgtcaa tcgtccgcaa catgccctgg tgatcatagg 180 
ttatgcaaga actcagacgt gttcaccgtt cttcaatacc aaatgcctct tctgtctggt 240 
tgcttccacc acgcgtccat gcatgtgcat gattctcttg tatataaaag tcccccttgc 300 
ccattctgtc tagtaccgga cttcaccaaa gcaccatcat g 341 
<210> SEQ ID NO 3 
<211> LENGTH: 340 
<212> TYPE: DNA 
<213> ORGANISM: Pin us taeda 
<400> SEQUENCE: 
actatagggc acgcgtggtc gacggcccgg gctggtaaag tgtgtgtttg cagggtgcag 60 
ataatggcag catgtatgac attagacata tggcattggc aaatgctatc gattttggca 120 
ctcatcactg taattgttgc aacatgtcaa tcgtctgcag catgccctgg cgatcatagg 180 
ttatgcaaga actcagatgt gttcaccatt cttcaatacc aaatgcctct tctgtctggt 240 
tgcttccacc acgcgtccat gcatgcacat gattctcttg tatataaaag tcccccttgc 300 
ccattctgtc tagtaccgac ttcaccaaag caccatcatg 340 
<210> SEQ ID NO 4 
<211> LENGTH: 340 
<212> TYPE: DNA 
<213> ORGANISM: Pin us taeda 
<400> SEQUENCE: 
actatagggc acgcgtggtc gacggcccgg gtggtaaagt gtgtgtttgc agggtgcaga 60 
taatggcagc atgtatgaca ttagacatat ggcattggca aatgctatcg attttggcac 120 
tcatcactgt aattgttgca acatgtcaat cgtctgcaac atgccctggc gatcataggt 180 
tatgcaagaa ctcagatgag ttcaccattc ttcaatacca aatgcctctt ctgtctggtt 240 
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gcttccacca cgcgtccatg catgcacatg attctcttgt atataaaagt cccccttgcc 300 
cattctgtct agtaccagac ttcaccaaag caccatcatg 340 
<210> SEQ ID NO 5 
<211> LENGTH: 565 
<212> TYPE: DNA 
<213> ORGANISM: Pinus taeda 
<220> FEATURE: 
<223> OTHER INFORMATION: n at 489 is a, c, g, or t 
<223> OTHER INFORMATION: n at 503 is a, c, g, or t 
<223> OTHER INFORMATION: n at 504 is a, c, g, or t 
<223> OTHER INFORMATION: n at 522 is a, c, g, or t 
<223> OTHER INFORMATION: n at 533 is a, c, g, or t 
<223> OTHER INFORMATION: n at 543 is a, c, g, or t 
<223> OTHER INFORMATION: n at 549 is a, c, g, or t 
<223> OTHER INFORMATION: n at 564 is a, c, g, or t 
<400> SEQUENCE: 5 
actatagggc acgcgtggtc gacggcccgg gctggtaaaa attcatttac taatcaaaac 60 
atgatgagat tcataaccaa agtctgttat aaaccatgat tataaccaac agattaacaa 120 
tgatagaaca accattaaaa ccacataata acaagtacat ttacacatgg aacacaagag 180 
gaaaatagct cttattaaca tatgaaaaat gtaactaggt caaggacttc cacgcaccaa 240 
ccaaccatag attgggctga accaaatctt tctttcaact aatcacccct aagccatatt 300 
cccagcatga atgtgggact tacaaaaaaa caaacaagga ttccttagga tttaccataa 360 
tccaccaagg gattcctagg cccaagccct catctataca actaggattt actgcaatcc 420 
caccaaggga ttcctaagcc caaacaagaa acacacacta ccaggattta gataaacccc 480 
ctttgtggng ctgctatcag ctnngtttct tttaccttct gnatatcttc tgnggacacc 540 
tgnctttana agccgattcc accnt 565 
<210> SEQ ID NO 6 
<211> LENGTH: 342 
<212> TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Seguence:consensus of 
sequences 1-4 
<223> OTHER INFORMATION: n at 23 is c or no base 
<223> OTHER INFORMATION: n at 32 is c or no base 
<223> OTHER INFORMATION: n at 40 is a or no base 
<223> OTHER INFORMATION: n at 157 is t or c 
<223> OTHER INFORMATION: n at 161 is g or a 
<223> OTHER INFORMATION: n at 172 is c or t 
<223> OTHER INFORMATION: n at 199 is t or c 
<223> OTHER INFORMATION: n at 223 is a or t 
<223> OTHER INFORMATION: n at 267 is c or t 
<223> OTHER INFORMATION: n at 268 is a or g 
<223> OTHER INFORMATION: n at 319 is g, a, or no base. 
<400> SEQUENCE: 6 
actatagggc acgcgtggtc ganggcccgg gntggtaaan gtgtgtgttt gcagggtgca 60 
gataatggca gcatgtatga cattagacat atggcattgg caaatgctgt cgattttggc 120 
actcatcact gtaattgttg caacatgtca atcgtcngca ncatgccctg gngatcatag 180 
gttatgcaag aactcagang tgttcaccat tcttcaatac canatgcctc ttctgtctgg 240 
ttgcttccac cacgcgtcca tgcatgnnca tgattctctt gtatataaaa gtcccccttg 300 
cccattctgt ctagtaccng acttcaccaa agcaccatca tg 342 
<210> SEQ ID NO 7 
<211> LENGTH: 1590 
16 
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-continued 
<212> TYPE: DNA 
<213> ORGANISM: Pie ea glauca 
<400> SEQUENCE: 
caagcatcat catggcttta gcttctttac ttatcattct tcttgcaatc tcctcctcct 60 
cggctgccct cactgagcca ctagccagca cggccaatcc agaagttttt cctgaatatc 120 
tcggccgagg ccgagggaga cgagaagaag agcgagagga gaatccatat gtattccaca 180 
gtgacagctt ccggaccaga gcatcatctg aagctggtga aatcagagct ctgccgaact 240 
ttggggaggt ctctgaactt cttgaaggga ttagaaaatt cagagttacc tgcattgaaa 300 
tgaaacccaa tacggtgatg ctccctcact atattgatgc gacatggatc ttatatgtta 360 
ctagaggaag aggttacata gcctatgtgc accagaatga gctggttaaa agaaagttgg 420 
aggaaggaga tgtattcggt gttccaagtg gtcatacatt ttatctcgtt aacaacgatg 480 
accataacac ccttcgcatt gctagtctcg tgcgtcccgt gtctacggtc cgaggagaat 540 
atcagccctt ctacgttgcg ggaggtcgga atcctcagac tgtttactct gcctttagcg 600 
atgatgttct cgaggctgca ttcaatacga acgtacagca gcttgaacgt attttcggtg 660 
gacacaaaag tggagtcata atccacgcaa atgaagaaca gattagagaa atgatgagga 720 
aacggggatt ttcagcagga tctatgtctg cacctgagca ccccaagcct ttcaaccttc 780 
ggaaccagaa gccagatttc gagaacgaaa atggcaggtt tactattgct ggtcccaaaa 840 
attatccttt tctagacgcg ctcgacgttt ctgttgggct tgccgatttg aatcctggat 900 
ccatgacagc cccatctctc aactcgaaat caacgtcaat cggcattgtt acgaatgggg 960 
aaggaaggat tgagatggcg tgcccgcacc ttggtcaaca tggttggtct agtccgcgcg 1020 
agagaggcga ccaagatatt acctaccaga gagtctgggc aaagctgagg accggcagcg 1080 
tttatattgt tcctgctggt catccaatca ccgagatagc ttcaacaaac agccgcctgc 1140 
aaatcttgtg gtttgatctt aatacccgcg gcaacgagag acaattcctg gcaggaaaga 1200 
acaatgtgct taacacgttg gagagggaga tcaggcagct atccttcaac gtaccacgtg 1260 
gggaagagat tgaagaagtg ttgcaggcgc aaaaggatca agtcatcctg agaggccccc 1320 
aacgacgaag ccgggacgag gcgaggagct cttcttagat ccatgtcatc atcgcagatc 1380 
gcattatgga cgacatgaca agagtttctc gacgttcact cttaatatct acttaaaaat 1440 
aagctatcca tatatgaagc ccaataaatg tgttcgaaga tgaactcttt ctgtctaaat 1500 
gaatgtatgt atgagtctaa caaagctatc gttgggctct tctcttgcta cttcaatgaa 1560 
atggaatgca gatcttctct taaaaaaaaa 1590 
<210> SEQ ID NO 8 
<211> LENGTH: 1413 
<212> TYPE: DNA 
<213> ORGANISM: Zamia furfuracea 
<400> SEQUENCE: 
tggtgggagg ccgcaatcca agggaccatg gcccatctgt gctctctacc gctaatggca 60 
gtgctaatgt tgctgcttgc atccgcttgc ttttcggaat tggaaataga agatccctat 120 
gtattcgacc aacgcagctt tgtgaccacg gtacagtgta aagccggtca gatcagagct 180 
ctacccaact ttagcgccgg cggcagatgt gaattgccac gagggcttgg ggattatagc 240 
gttgctcaga taagcttgga accgagatct gtgctgcttc ctcattatat tgaggcagat 300 
ttggctttat acgtcacagg aggaagagga agggttgcgt ttgttcatga agagagactg 360 
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gtagaaaggc agctgcggga cggagatgtg tacgcaattg ctgcaggtat accgttttat 420 
attctcaaca cggatgacag tcggcgcctt ttcattcact gtctcctgcg cacgcagtgc 480 
tctactaccg gactctatga gtcgttttac gtggtgggag gccgcaatcc gcagaatgtt 540 
ttgtcccaat tcagcgagga cgttctgcaa gctgcattca acagttcgaa ggcggtcctg 600 
gatcctatgc tggtaagtgg gtttaacaga ggggccataa ttagagtgtc cagagaacaa 660 
atggaaaggc tgagcagggg tagaattaag ggattcggag ggtctgagga gccacagccc 720 
ttcaacctgc tctacaggaa ccccgacttt tccaacaaca acggtgaaat tttcacagca 780 
gacgccgcag atcatcgcgt tttacgccgg ctgaatgttg gagtgcagct tctcaactta 840 
aagccgcgct caatgacggc accgcattac gatacaaggt cgaccagaat tggcatcgtt 900 
aggaacggga ggggaatcct cgaattagtg cgcccgcaag aacaagaaca acaacaacaa 960 
caacaacaag gtcccacata ccagaaacta cgggccaacc ttaaccccgg cactgttttc 1020 
ctaacccgcc ccggctaccc ttccactgta attgcctctg gcaatgaggc attgcagata 1080 
ttgtacctcg acaattattc ccaaggcagt cgcaggcaat tcctcgcagg aaggagcaat 1140 
gtgttgagat atctgcctag ggaaattaag cgattggttt tcccatcttc cgctgaggag 1200 
atagaggcaa ccttggaagc gcaggaagat gaggttctcc tcaacgcgca acaagggcgg 1260 
gccgaccagt agtagagaaa ccgtggactc cacttggtgc ggctcagtat aaacatatgg 1320 
acttctccct agtaccttgc cctgtacagc tcgtcgttct ccatacccac ggaaataaat 1380 
aaatgggatc ttgcctcgca tccgcacccc ttt 1413 
<210> SEQ ID NO 9 
<211> LENGTH: 22 
<212> TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence:PCR primer 
<400> SEQUENCE: 9 
gagacgagaa gaagagcgag ag 
<210> SEQ ID NO 10 
<211> LENGTH: 22 
<212> TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence:PCR primer 
<400> SEQUENCE: 10 
tgaagtagca agagaagagc cc 
<210> SEQ ID NO 11 
<211> LENGTH: 20 
<212> TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence:3' RACE 
primer 
<400> SEQUENCE: 11 
acatggttgg tctagtccgc 
<210> SEQ ID NO 12 
<211> LENGTH: 32 
<212> TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
<220> FEATURE: 
22 
22 
20 
20 
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<223> OTHER INFORMATION: Description of Artificial Sequence:Gene 
Specific Primer 
<400> SEQUENCE: 12 
cgtagaccac tgtacgcagg agactggtaa tg 
<210> SEQ ID NO 13 
<211> LENGTH: 31 
<212> TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence:Gene 
Specific Primer 
<400> SEQUENCE: 13 
ctccttcctc caactttctt ttcaccagtt c 
<210> SEQ ID NO 14 
<211> LENGTH: 22 
<212> TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence:PCR primer 
<400> SEQUENCE: 14 
gagacgagaa gaagagcgag ag 
<210> SEQ ID NO 15 
<211> LENGTH: 23 
<212> TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Sequence:PCR primer 
<400> SEQUENCE: 15 
tgaagtagca agagaaagag ccc 
<210> SEQ ID NO 16 
<211> LENGTH: 1581 
<212> TYPE: DNA 
<213> ORGANISM: Pin us taeda 
<400> SEQUENCE: 16 
aaagcaccat catggctttt gtttctttac ttaccattct tcaagcaatc tcctcctgct 
ccgttgctct cactgagcca ctagccactg tggccaatca aggagttttt cctgaagatc 
atgggcgagg gcaccagaga cgagaagaag aacgagagga gaatccgtac gtattccaca 
gtgacagatt caggatgaga gcgtcatctg acgctggtga aatcagagct ctccccaact 
ttggtgaggc ctctgaactt cttgaaggga ttagtaaata cagagttacc tgcattgaaa 
tgagacccaa cacggtcatg ctccctcact atcttgacgc gacatggatt ttatatgtta 
ctggaggaag aggttacata gcttacgtgc accagaatga actggtgaaa agaaagttgg 
aggaaggaga tgtatttggt gttccaagtg gtcatacatt ttatctcgtt aacaacgatg 
accacaacag ccttcgcatt accagtctcc tgcgtacagt gtctacgatg cgaggagaat 
atgagcccta ctacgttgct ggaggtcgga atcctgagac tgtttactct gcctttagcg 
atgatgttct cgaagctgca ttcaatacga acgttataga agctagaaca cattttccgg 
tgcacataga acgggagtca tattccatgg caaatgaaga acagattaga gaaatgttga 
ggaaacgggg attttcagca gaatccatgt ctgcatctga gcacccaaag ccttttaacc 
ttcggaacca gaagccagat ttcgagaacg acaatggcag gtttactaga gctggtccca 
22 
32 
31 
22 
23 
60 
120 
180 
240 
300 
360 
420 
480 
540 
600 
660 
720 
780 
840 
US 6,462,257 Bl 
23 
-continued 
atgaaaatcc tcttcttgac gcggtcgatg ttactgctgg gtttggcgtt ttgaatcctg 900 
gaaccatgac agccccatct cacaacacga aagcaacctc aatcgccatt gtcacacagg 960 
gggagggaag gattgagatg gcgtgcccgc accttggtca acatggctgg tctagtcggc 1020 
gcgagaaagg cgatcaggaa attaattacc agagggtacg ggcaaggctg agaaccggca 1080 
ccgtttacgt tgttcctgca ggtcatccaa tcaccgagat agcttgcaca gagggccacc 1140 
ttgaaatctt gtggtttgat attaatacga gcggcaacga gagacaattc ctggcaggaa 1200 
agtacaatgt gcttcaaacg ctggagaagg aggtcaggca gatatccttc aacataccac 1260 
gtggggaaga gctggatgaa gttttacggc ggcaaaagga tcaagtcatc ctcagagggc 1320 
cccaaatgca aaggcgagac gagccaagga gctcttctta gatccatgcc atcatcgcag 1380 
ctcgcatcat ggacgacaag actagagttt ctccacgttc actctttagt atctacttaa 1440 
gaataagtta tgcatatatg aagcccaaaa aatgtgttcg aagatgagct ccttttatct 1500 
taatgaatgt atatatgagt ttcaacaaac ctatcgttgg gctcttctct tgctacttca 1560 
atgacatgga atgctgatct t 1581 
<210> SEQ ID NO 17 
<211> LENGTH: 523 
<212> TYPE: PRT 
<213> ORGANISM: Pinus taeda 
<400> SEQUENCE: 17 
Ser Thr Ile Met Ala Phe Val Ser Leu Leu Thr Ile Leu Gln Ala Ile 
5 10 15 
Ser Ser Cys Ser Val Ala Leu Thr Glu Pro Leu Ala Thr Val Ala Asn 
20 25 30 
Gln Gly Val Phe Pro Glu Asp His Gly Arg Gly His Gln Arg Arg Glu 
35 40 45 
Glu Glu Arg Glu Glu Asn Pro Tyr Val Phe His Ser Asp Arg Phe Arg 
50 55 60 
Met Arg Ala Ser Ser Asp Ala Gly Glu Ile Arg Ala Leu Pro Asn Phe 
65 70 75 80 
Gly Glu Ala Ser Glu Leu Leu Glu Gly Ile Ser Lys Tyr Arg Val Thr 
85 90 95 
Cys Ile Glu Met Arg Pro Asn Thr Val Met Leu Pro His Tyr Leu Asp 
100 105 110 
Ala Thr Trp Ile Leu Tyr Val Thr Gly Gly Arg Gly Tyr Ile Ala Tyr 
115 120 125 
Val His Gln Asn Glu Leu Val Lys Arg Lys Leu Glu Glu Gly Asp Val 
130 135 140 
Phe Gly Val Pro Ser Gly His Thr Phe Tyr Leu Val Asn Asn Asp Asp 
145 150 155 160 
His Asn Ser Leu Arg Ile Thr Ser Leu Leu Arg Thr Val Ser Thr Met 
165 170 175 
Arg Gly Glu Tyr Glu Pro Tyr Tyr Val Ala Gly Gly Arg Asn Pro Glu 
180 185 190 
Thr Val Tyr Ser Ala Phe Ser Asp Asp Val Leu Glu Ala Ala Phe Asn 
195 200 205 
Thr Asn Val Ile Glu Ala Arg Thr His Phe Pro Val His Ile Glu Arg 
210 215 220 
Glu Ser Tyr Ser Met Ala Asn Glu Glu Gln Ile Arg Glu Met Leu Arg 
225 230 235 240 
24 
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Lys Arg Gly Phe Ser Ala Glu Ser Met Ser Ala Ser Glu His Pro Lys 
245 250 255 
Pro Phe Asn Leu Arg Asn Gln Lys Pro Asp Phe Glu Asn Asp Asn Gly 
260 265 270 
Arg Phe Thr Arg Ala Gly Pro Asn Glu Asn Pro Leu Leu Asp Ala Val 
275 280 285 
Asp Val Thr Ala Gly Phe Gly Val Leu Asn Pro Gly Thr Met Thr Ala 
290 295 300 
Pro Ser His Asn Thr Lys Ala Thr Ser Ile Ala Ile Val Thr Gln Gly 
305 310 315 320 
Glu Gly Arg Ile Glu Met Ala Cys Pro His Leu Gly Gln His Gly Trp 
325 330 335 
Ser Ser Arg Arg Glu Lys Gly Asp Gln Glu Ile Asn Tyr Gln Arg Val 
340 345 350 
Arg Ala Arg Leu Arg Thr Gly Thr Val Tyr Val Val Pro Ala Gly His 
355 360 365 
Pro Ile Thr Glu Ile Ala Cys Thr Glu Gly His Leu Glu Ile Leu Trp 
370 375 380 
Phe Asp Ile Asn Thr Ser Gly Asn Glu Arg Gln Phe Leu Ala Gly Lys 
385 390 395 400 
Tyr Asn Val Leu Gln Thr Leu Glu Lys Glu Val Arg Gln Ile Ser Phe 
405 410 415 
Asn Ile Pro Arg Gly Glu Glu Leu Asp Glu Val Leu Arg Arg Gln Lys 
420 425 430 
Asp Gln Val Ile Leu Arg Gly Pro Gln Met Gln Arg Arg Asp Glu Pro 
435 440 445 
Arg Ser Ser Ser Ile His Ala Ile Ile Ala Ala Arg Ile Met Asp Asp 
450 455 460 
Lys Thr Arg Val Ser Pro Arg Ser Leu Phe Ser Ile Tyr Leu Arg Ile 
465 470 475 480 
Ser Tyr Ala Tyr Met Lys Pro Lys Lys Cys Val Arg Arg Ala Pro Phe 
485 490 495 
Ile Leu Met Asn Val Tyr Met Ser Phe Asn Lys Pro Ile Val Gly Leu 
500 505 510 
Phe Ser Cys Tyr Phe Asn Asp Met Glu Cys Ser 
515 520 
<210> SEQ ID NO 18 
<211> LENGTH: 448 
<212> TYPE: PRT 
<213> ORGANISM: Picea glauca 
<400> SEQUENCE: 18 
Met Ala Leu Ala Ser Leu Leu Ile Ile Leu Leu Ala Ile Ser Ser Ser 
1 5 10 15 
Ser Ala Ala Leu Thr Glu Pro Leu Ala Ser Thr Ala Asn Pro Glu Val 
20 25 30 
Phe Pro Glu Tyr Leu Gly Arg Gly Arg Gly Arg Arg Glu Glu Glu Arg 
35 40 45 
Glu Glu Asn Pro Tyr Val Phe His Ser Asp Ser Phe Arg Thr Arg Ala 
50 55 60 
Ser Ser Glu Ala Gly Glu Ile Arg Ala Leu Pro Asn Phe Gly Glu Val 
65 70 75 80 
Ser Glu Leu Leu Glu Gly Ile Arg Lys Phe Arg Val Thr Cys Ile Glu 
26 
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85 90 95 
Met Lys Pro Asn Thr Val Met Leu Pro His Tyr Ile Asp Ala Thr Trp 
100 105 110 
Ile Leu Tyr Val Thr Arg Gly Arg Gly Tyr Ile Ala Tyr Val His Gln 
115 120 125 
Asn Glu Leu Val Lys Arg Lys Leu Glu Glu Gly Asp Val Phe Gly Val 
130 135 140 
Pro Ser Gly His Thr Phe Tyr Leu Val Asn Asn Asp Asp His Asn Thr 
145 150 155 160 
Leu Arg Ile Ala Ser Leu Val Arg Pro Val Ser Thr Val Arg Gly Glu 
165 170 175 
Tyr Gln Pro Phe Tyr Val Ala Gly Gly Arg Asn Pro Gln Thr Val Tyr 
180 185 190 
Ser Ala Phe Ser Asp Asp Val Leu Glu Ala Ala Phe Asn Thr Asn Val 
195 200 205 
Gln Gln Leu Glu Arg Ile Phe Gly Gly His Lys Ser Gly Val Ile Ile 
210 215 220 
His Ala Asn Glu Glu Gln Ile Arg Glu Met Met Arg Lys Arg Gly Phe 
225 230 235 240 
Ser Ala Gly Ser Met Ser Ala Pro Glu His Pro Lys Pro Phe Asn Leu 
245 250 255 
Arg Asn Gln Lys Pro Asp Phe Glu Asn Glu Asn Gly Arg Phe Thr Ile 
260 265 270 
Ala Gly Pro Lys Asn Tyr Pro Phe Leu Asp Ala Leu Asp Val Ser Val 
275 280 285 
Gly Leu Ala Asp Leu Asn Pro Gly Ser Met Thr Ala Pro Ser Leu Asn 
290 295 300 
Ser Lys Ser Thr Ser Ile Gly Ile Val Thr Asn Gly Glu Gly Arg Ile 
305 310 315 320 
Glu Met Ala Cys Pro His Leu Gly Gln His Gly Trp Ser Ser Pro Arg 
325 330 335 
Glu Arg Gly Asp Gln Asp Ile Thr Tyr Gln Arg Val Trp Ala Lys Leu 
340 345 350 
Arg Thr Gly Ser Val Tyr Ile Val Pro Ala Gly His Pro Ile Thr Glu 
355 360 365 
Ile Ala Ser Thr Asn Ser Arg Leu Gln Ile Leu Trp Phe Asp Leu Asn 
370 375 380 
Thr Arg Gly Asn Glu Arg Gln Phe Leu Ala Gly Lys Asn Asn Val Leu 
385 390 395 400 
Asn Thr Leu Glu Arg Glu Ile Arg Gln Leu Ser Phe Asn Val Pro Arg 
405 410 415 
Gly Glu Glu Ile Glu Glu Val Leu Gln Ala Gln Lys Asp Gln Val Ile 
420 425 430 
Leu Arg Gly Pro Gln Arg Arg Ser Arg Asp Glu Ala Arg Ser Ser Ser 
435 440 445 
<210> SEQ ID NO 19 
<211> LENGTH: 1596 
<212> TYPE: DNA 
<213> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Description of Artificial Seguence:Vicilin-like 
gene with TA linkers 
<400> SEQUENCE: 19 
28 
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aattcggctt aaagcaccat catggctttt gtttctttac ttaccattct tcaagcaatc 60 
tcctcctgct ccgttgctct cactgagcca ctagccactg tggccaatca aggagttttt 120 
cctgaagatc atgggcgagg gcaccagaga cgagaagaag aacgagagga gaatccgtac 180 
gtattccaca gtgacagatt caggatgaga gcgtcatctg acgctggtga aatcagagct 240 
ctccccaact ttggtgaggc ctctgaactt cttgaaggga ttagtaaata cagagttacc 300 
tgcattgaaa tgagacccaa cacggtcatg ctccctcact atcttgacgc gacatggatt 360 
ttatatgtta ctggaggaag aggttacata gcttacgtgc accagaatga actggtgaaa 420 
agaaagttgg aggaaggaga tgtatttggt gttccaagtg gtcatacatt ttatctcgtt 480 
aacaacgatg accacaacag ccttcgcatt accagtctcc tgcgtacagt gtctacgatg 540 
cgaggagaat atgagcccta ctacgttgct ggaggtcgga atcctgagac tgtttactct 600 
gcctttagcg atgatgttct cgaagctgca ttcaatacga acgttataga agctagaaca 660 
cattttccgg tgcacataga acgggagtca tattccatgg caaatgaaga acagattaga 720 
gaaatgttga ggaaacgggg attttcagca gaatccatgt ctgcatctga gcacccaaag 780 
ccttttaacc ttcggaacca gaagccagat ttcgagaacg acaatggcag gtttactaga 840 
gctggtccca atgaaaatcc tcttcttgac gcggtcgatg ttactgctgg gtttggcgtt 900 
ttgaatcctg gaaccatgac agccccatct cacaacacga aagcaacctc aatcgccatt 960 
gtcacacagg gggagggaag gattgagatg gcgtgcccgc accttggtca acatggctgg 1020 
tctagtcggc gcgagaaagg cgatcaggaa attaattacc agagggtacg ggcaaggctg 1080 
agaaccggca ccgtttacgt tgttcctgca ggtcatccaa tcaccgagat agcttgcaca 1140 
gagggccacc ttgaaatctt gtggtttgat attaatacga gcggcaacga gagacaattc 1200 
ctggcaggaa agtacaatgt gcttcaaacg ctggagaagg aggtcaggca gatatccttc 1260 
aacataccac gtggggaaga gctggatgaa gttttacggc ggcaaaagga tcaagtcatc 1320 
ctcagagggc cccaaatgca aaggcgagac gagccaagga gctcttctta gatccatgcc 1380 
atcatcgcag ctcgcatcat ggacgacaag actagagttt ctccacgttc actctttagt 1440 
atctacttaa gaataagtta tgcatatatg aagcccaaaa aatgtgttcg aagatgagct 1500 
ccttttatct taatgaatgt atatatgagt ttcaacaaac ctatcgttgg gctcttctct 1560 
tgctacttca atgacatgga atgctgatct tagccg 1596 
What is claimed is: 
1. An isolated promoter compnsmg a nucleic acid 
selected from the group consisting of 
6. The isolated promoter of claim 5, wherein the isolated 
promoter has a nucleotide sequence selected from the group 
50 consisting of SEQ ID NOS:l-6. 
(a) a nucleic acid molecule having a nucleotide sequence 
selected from the group consisting of SEQ ID 
NOS:l-6; and 
(b) a nucleic acid molecule of from 100 to 400 
nucleotides, which is a fragment of (a), wherein the 
fragment retains promoter activity of (a). 
2. The isolated promoter of claim 1 wherein the isolated 
promoter is operably linked to a DNA sequence encoding a 
desired polypeptide. 
3. The isolated promoter of claim 1, wherein the nucleic 
acid molecule has the nucleotide sequence of SEQ ID NO:l. 
4. A fragment of the isolated promoter of claim 1, wherein 
The fragment retains promoter activity, and wherein the 
fragment has a nucleotide sequence which is a portion of 
SEQ ID NO:l. 
5. The isolated promoter of claim 2, wherein the isolated 
promoter is a vicilin promoter. 
7. The isolated promoter of claim 6, wherein the isolated 
promoter has the nucleotide sequence of SEQ ID NO:l. 
8. A method of expressing a desired polypeptide in a plant, 
comprising the step of transforming said plant with a 
55 promoter-gene construct comprising a promoter selected 
from the group consisting of SEQ ID NOS:l-6 operably 
linked to a desired DNA sequence encoding the desired 
polypeptide, whereby the desired polypeptide is expressed 
in the plant. 
9. The method of claim 8 wherein said polypeptide is a 
60 structural protein. 
10. The method of claim 8 wherein said polypeptide is a 
seed storage protein (SSP). 
11. The method of claim 8 wherein said DNA sequence is 
selected from the group consisting of a hererologous DNA 
65 sequence and a non-heterologous DNA sequence. 
12. The method of claim 11 wherein said heterologous 
DNA sequence is a reporter DNA sequence encoding a 
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protein selected from the group consisting of green fluores-
cent protein, alkaline phosphatase, chloramphenicol 
acetyltransferase, B-glucuronidase, firefly luciferase, bacte-
rial luciferase and ~-galactosidase. 
13. The method of claim 8 wherein said promoter com-
prises a nucleic acid molecule having the sequence of SEQ 
ID NO:l. 
14. The method of claim 8 wherein the promoter is 
inducible, and further comprising the step of inducing 
expression of said DNA sequence with an inducer. 
15. The method of claim 14 wherein said inducer is 
selected from the group consisting of ABA, heat, and light. 
32 
mater selected from the group consisting of SEQ ID NOS: 
1-6 operably linked to a reporter DNA sequence and moni-
toring the level of expression of said reporter DNA 
sequence, whereby expression of the reporter DNA 
5 sequence provides a quantitative marker for monitoring 
embryo development. 
18. The method of claim 17 wherein said reporter DNA 
sequence encodes a protein selected from the group con-
sisting of green fluorescent protein, alkaline phosphatase, 
10 
chloramphenicol acetyltransferase, B-glucuronidase, firefly 
luciferase, bacterial luciferase, and ~-galactosidase. 
19. A transgenic plant comprising a promoter operably 
linked to a desired DNA sequence, wherein said promoter is 
15 selected from the group consisting of SEQ ID Nos: 1-6. 
20. The plant of claim 15 wherein said plant is a gym-
16. A method expressing a desired polypeptide in plant, 
comprising the step of transforming said plant with a 
promoter-gene construct comprising a nucleic acid molecule 
fragment having a nucleotide sequence of from 100 to 400 
nucleotides selected from the group consisting of SEQ ID 
NO:l-6 and operably linked to a DNA sequence encoding 
the desired polypeptide wherein said fragment retains pro-
moter activity wherein the fragment retaims promoter activ- 20 
ity nucleic acid molecule haxing a sequence selected from 
teh group consisting of SEQ ID NO:l-6. 
nosperm. 
21. The plant of claim 20 wherein said gymnosperm is a 
conifer. 
22. A transgenic plant comprising the promoter of claim 
1. 
23. A transgenic plant comprising the promoter of claim 
7. 17. A method of monitoring embryo development of a 
plant embryo comprising the step of transforming said 
embryo with a promoter-gene construct comprising a pro-
* * * * * 
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